| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-20 | 2009-09-30 | 13F-HR | California State Teachers Retirement System | Institution | 299,294 | Sold Some | -950 | -0.31 % | $11,534,791 | $11,534,791 | $0 | 0.00 % | $0 | | | | | | News Article | History of California State Teachers Retirement System Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-20 | 2009-09-30 | 13F-HR/A | Ing Investment Management Europe B V | Institution | 15,063 | Added More | 24 | 0.15 % | $580,528 | $580,528 | $0 | 0.00 % | $0 | | | | | | News Article | History of Ing Investment Management Europe B V Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-20 | 2009-09-30 | 13F-HR/A | Janney Montgomery Scott Llc | Institution | 5,628 | New Holding | 5,628 | 100 % | $216,903 | $216,903 | $0 | 0.00 % | $0 | | | | | | News Article | History of Janney Montgomery Scott Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-20 | 2009-09-30 | 13F-HR/A | Janus Capital Management Llc | Institution | 5,245,819 | Sold Some | -375,330 | -6.67 % | $202,173,864 | $202,173,864 | $0 | 0.00 % | $0 | | | | | | News Article | History of Janus Capital Management Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-20 | 2009-09-30 | N-Q | Oppenheimer Equity Fund Inc - Oppenheimer Equity Fund Inc | Large-Cap Core | | Sold All | -118,350 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Oppenheimer Equity Fund Inc - Oppenheimer Equity Fund Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-19 | 2009-09-30 | 13F-HR/A | Rbc Asset Management Inc | Institution | 21,200 | New Holding | 21,200 | 100 % | $825,104 | $817,048 | $-8,056 | -0.97 % | $-8,056 | | | | | | News Article | History of Rbc Asset Management Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-18 | 2009-09-30 | 13F-HR/A | Adage Capital Partners Gp Llc | Institution | 2,250,000 | Sold Some | -650,000 | -22.41 % | $88,897,500 | $86,715,000 | $-2,182,500 | -2.45 % | $630,500 | | | | | | News Article | History of Adage Capital Partners Gp Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Amvescap Plc | Institution | 2,164,689 | Added More | 154,938 | 7.70 % | $87,756,492 | $83,427,114 | $-4,329,378 | -4.93 % | $-309,876 | | | | | | News Article | History of Amvescap Plc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Castleark Management Llc | Institution | 57,930 | No Change | 0 | 0 % | $2,348,482 | $2,232,622 | $-115,860 | -4.93 % | $0 | | | | | | News Article | History of Castleark Management Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Credit Suisse First Boston | Institution | 124,436 | Added More | 3,030 | 2.49 % | $5,044,635 | $4,795,763 | $-248,872 | -4.93 % | $-6,060 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Wells Fargo And Co | Institution | 617,348 | Sold Some | -26,404 | -4.10 % | $25,027,288 | $23,792,592 | $-1,234,696 | -4.93 % | $52,808 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Aletheia Research And Management Inc | Institution | | Sold All | -1,972 | -100 % | | | | -4.83 % | $3,865 | | | | | | News Article | History of Aletheia Research And Management Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Alger Fred Management Inc | Institution | 309,342 | New Holding | 309,342 | 100 % | $12,528,351 | $11,922,041 | $-606,310 | -4.83 % | $-606,310 | | | | | | News Article | History of Alger Fred Management Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | American International Group Inc | Institution | 436,482 | Added More | 28,737 | 7.04 % | $17,677,521 | $16,822,016 | $-855,505 | -4.83 % | $-56,325 | | | | | | News Article | History of American International Group Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Aqr Capital Management Llc | Institution | 9,198 | New Holding | 9,198 | 100 % | $372,519 | $354,491 | $-18,028 | -4.83 % | $-18,028 | | | | | | News Article | History of Aqr Capital Management Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Argyll Research Llc | Institution | 300,000 | New Holding | 300,000 | 100 % | $12,150,000 | $11,562,000 | $-588,000 | -4.83 % | $-588,000 | | | | | | News Article | History of Argyll Research Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bam Management Llc | No Data | 158,909 | Sold Some | -43,842 | -21.62 % | $6,435,815 | $6,124,353 | $-311,462 | -4.83 % | $85,930 | | | | | | News Article | History of Bam Management Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bancorpsouth Inc | Institution | | Sold All | -35 | -100 % | | | | -4.83 % | $69 | | | | | | News Article | History of Bancorpsouth Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bb Biotech Ag | Institution | 4,784,700 | Added More | 34,700 | 0.73 % | $193,780,350 | $184,402,338 | $-9,378,012 | -4.83 % | $-68,012 | | | | | | News Article | History of Bb Biotech Ag Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Brookside Capital Management Llc | Institution | 143,404 | Sold Some | -3,973,346 | -96.51 % | $5,807,862 | $5,526,790 | $-281,072 | -4.83 % | $7,787,758 | | | | | | News Article | History of Brookside Capital Management Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Brown Advisory Securities Llc | Institution | 6,645 | No Change | 0 | 0 % | $269,123 | $256,098 | $-13,024 | -4.83 % | $0 | | | | | | News Article | History of Brown Advisory Securities Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Brown Brothers Harriman And Co | Institution | 6,972 | No Change | 0 | 0 % | $282,366 | $268,701 | $-13,665 | -4.83 % | $0 | | | | | | News Article | History of Brown Brothers Harriman And Co Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Capital International S A | Institution | 10,100 | Sold Some | -5,500 | -35.25 % | $409,050 | $389,254 | $-19,796 | -4.83 % | $10,780 | | | | | | News Article | History of Capital International S A Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Capital Research Global Investors | Institution | 5,749,000 | Added More | 414,000 | 7.76 % | $232,834,500 | $221,566,460 | $-11,268,040 | -4.83 % | $-811,440 | | | | | | News Article | History of Capital Research Global Investors Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Capital World Investors | Institution | 9,711,000 | No Change | 0 | 0 % | $393,295,500 | $374,261,940 | $-19,033,560 | -4.83 % | $0 | | | | | | News Article | History of Capital World Investors Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Capstone Investment Advisors Llc | Institution | | Sold All | -14,553 | -100 % | | | | -4.83 % | $28,524 | | | | | | News Article | History of Capstone Investment Advisors Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Citadel L P | Institution | | Sold All | -42,650 | -100 % | | | | -4.83 % | $83,594 | | | | | | News Article | History of Citadel L P Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Concert Wealth Management Inc | No Data | 99 | Sold Some | -345 | -77.70 % | $4,010 | $3,815 | $-194 | -4.83 % | $676 | | | | | | News Article | History of Concert Wealth Management Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Eaton Vance Management | Institution | 95,564 | Sold Some | -784 | -0.81 % | $3,870,342 | $3,683,037 | $-187,305 | -4.83 % | $1,537 | | | | | | News Article | History of Eaton Vance Management Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Eaton Vance Management | Institution | 95,564 | Sold Some | -889 | -0.92 % | $3,870,342 | $3,683,037 | $-187,305 | -4.83 % | $1,742 | | | | | | News Article | History of Eaton Vance Management Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Employees Retirement System Of Texas | Institution | 44,000 | Sold Some | -8,000 | -15.38 % | $1,782,000 | $1,695,760 | $-86,240 | -4.83 % | $15,680 | | | | | | News Article | History of Employees Retirement System Of Texas Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fifth Third Bancorp | Institution | 948 | No Change | 0 | 0 % | $38,394 | $36,536 | $-1,858 | -4.83 % | $0 | | | | | | News Article | History of Fifth Third Bancorp Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fmr Corp | Institution | 20,800,642 | Sold Some | -401,158 | -1.89 % | $842,426,001 | $801,656,743 | $-40,769,258 | -4.83 % | $786,270 | | | | | | News Article | History of Fmr Corp Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Galleon Management L P | Institution | 235,000 | Added More | 175,000 | 291.66 % | $9,517,500 | $9,056,900 | $-460,600 | -4.83 % | $-343,000 | | | | | | News Article | History of Galleon Management L P Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ing Groep Nv | Institution | 290,081 | Added More | 14,696 | 5.33 % | $11,748,281 | $11,179,722 | $-568,559 | -4.83 % | $-28,804 | | | | | | News Article | History of Ing Groep Nv Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Loomis Sayles And Co L P | Institution | 4,251,354 | Sold Some | -141,752 | -3.22 % | $172,179,837 | $163,847,183 | $-8,332,654 | -4.83 % | $277,834 | | | | | | News Article | History of Loomis Sayles And Co L P Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Madison Square Investors Llc | No Data | 96,198 | Added More | 82,527 | 603.66 % | $3,896,019 | $3,707,471 | $-188,548 | -4.83 % | $-161,753 | | | | | | News Article | History of Madison Square Investors Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Millennium Management Llc | Institution | 239,776 | Sold Some | -135,224 | -36.05 % | $9,710,928 | $9,240,967 | $-469,961 | -4.83 % | $265,039 | | | | | | News Article | History of Millennium Management Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Morgan Stanley | Institution | 884,841 | Added More | 343,802 | 63.54 % | $35,836,061 | $34,101,772 | $-1,734,288 | -4.83 % | $-673,852 | | | | | | News Article | History of Morgan Stanley Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | New York State Teachers Retirement System | Institution | 402,100 | New Holding | 402,100 | 100 % | $16,285,050 | $15,496,934 | $-788,116 | -4.83 % | $-788,116 | | | | | | News Article | History of New York State Teachers Retirement System Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Co Of Connecticut | Institution | | Sold All | -81,899 | -100 % | | | | -4.83 % | $160,522 | | | | | | News Article | History of Northern Trust Co Of Connecticut Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 1,364,704 | Added More | 26,602 | 1.98 % | $55,270,512 | $52,595,692 | $-2,674,820 | -4.83 % | $-52,140 | | | | | | News Article | History of Northern Trust Corp Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Oppenheimer Funds Inc | Institution | 1,348,938 | Sold Some | -122,329 | -8.31 % | $54,631,989 | $51,988,071 | $-2,643,918 | -4.83 % | $239,765 | | | | | | News Article | History of Oppenheimer Funds Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Orbimed Advisors Llc | Institution | 2,268,700 | Sold Some | -441,600 | -16.29 % | $91,882,350 | $87,435,698 | $-4,446,652 | -4.83 % | $865,536 | | | | | | News Article | History of Orbimed Advisors Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Perceptive Advisors Llc | Institution | | Sold All | -25,000 | -100 % | | | | -4.83 % | $49,000 | | | | | | News Article | History of Perceptive Advisors Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Quantlab Capital Management Ltd | Institution | | Sold All | -7,151 | -100 % | | | | -4.83 % | $14,016 | | | | | | News Article | History of Quantlab Capital Management Ltd Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Rafferty Asset Management Llc | Institution | 2,046 | Added More | 571 | 38.71 % | $82,863 | $78,853 | $-4,010 | -4.83 % | $-1,119 | | | | | | News Article | History of Rafferty Asset Management Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Raptor Capital Management Lp | No Data | | Sold All | -325,709 | -100 % | | | | -4.83 % | $638,390 | | | | | | News Article | History of Raptor Capital Management Lp Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Sac Capital Advisors Lp | No Data | | Sold All | -75,100 | -100 % | | | | -4.83 % | $147,196 | | | | | | News Article | History of Sac Capital Advisors Lp Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Samlyn Capital Llc | Institution | 230,200 | Sold Some | -83,900 | -26.71 % | $9,323,100 | $8,871,908 | $-451,192 | -4.83 % | $164,444 | | | | | | News Article | History of Samlyn Capital Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Shaw D E And Co Inc | Institution | 7,033,651 | Sold Some | -1,855,470 | -20.87 % | $284,862,866 | $271,076,910 | $-13,785,956 | -4.83 % | $3,636,721 | | | | | | News Article | History of Shaw D E And Co Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Sigma Capital Management Llc | Institution | | Sold All | -35,000 | -100 % | | | | -4.83 % | $68,600 | | | | | | News Article | History of Sigma Capital Management Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Silvercrest Asset Management Group Llc | Institution | 5,500 | New Holding | 5,500 | 100 % | $222,750 | $211,970 | $-10,780 | -4.83 % | $-10,780 | | | | | | News Article | History of Silvercrest Asset Management Group Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | State Treasurer State Of Michigan | Institution | 114,400 | Added More | 2,900 | 2.60 % | $4,633,200 | $4,408,976 | $-224,224 | -4.83 % | $-5,684 | | | | | | News Article | History of State Treasurer State Of Michigan Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Trustmark National Bank Trust Department | Institution | 32,000 | No Change | 0 | 0 % | $1,296,000 | $1,233,280 | $-62,720 | -4.83 % | $0 | | | | | | News Article | History of Trustmark National Bank Trust Department Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Two Sigma Investments Llc | Institution | 577,815 | Added More | 532,800 | 1183.60 % | $23,401,508 | $22,268,990 | $-1,132,517 | -4.83 % | $-1,044,288 | | | | | | News Article | History of Two Sigma Investments Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ubs Global Asset Management Americas Inc | Institution | 479,227 | Added More | 20,500 | 4.46 % | $19,408,694 | $18,469,409 | $-939,285 | -4.83 % | $-40,180 | | | | | | News Article | History of Ubs Global Asset Management Americas Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Us Bancorp De | Institution | 36 | Sold Some | -29 | -44.61 % | $1,458 | $1,387 | $-71 | -4.83 % | $57 | | | | | | News Article | History of Us Bancorp De Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Vicis Capital Llc | Institution | | Sold All | -33,943 | -100 % | | | | -4.83 % | $66,528 | | | | | | News Article | History of Vicis Capital Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Weiss Multi-Strategy Advisers Llc | Institution | 87,500 | Added More | 22,700 | 35.03 % | $3,543,750 | $3,372,250 | $-171,500 | -4.83 % | $-44,492 | | | | | | News Article | History of Weiss Multi-Strategy Advisers Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wellington Management Co Llp | Institution | 6,649,614 | Sold Some | -1,826,886 | -21.55 % | $269,309,367 | $256,276,124 | $-13,033,243 | -4.83 % | $3,580,697 | | | | | | News Article | History of Wellington Management Co Llp Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wooster Capital Management L P | Institution | 25,000 | No Change | 0 | 0 % | $1,012,500 | $963,500 | $-49,000 | -4.83 % | $0 | | | | | | News Article | History of Wooster Capital Management L P Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-16 | 2009-06-30 | 13F-HR/A | Brown Brothers Harriman And Co | Institution | 6,972 | Sold Some | -1,300 | -15.71 % | $282,366 | $268,701 | $-13,665 | -4.83 % | $2,548 | | | | | | News Article | History of Brown Brothers Harriman And Co Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ameriprise Financial Inc | Institution | 425,843 | Sold Some | -32,537 | -7.09 % | $17,280,709 | $16,411,989 | $-868,720 | -5.02 % | $66,375 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Axa | Institution | 3,333,860 | Added More | 2,357,262 | 241.37 % | $135,288,039 | $128,486,964 | $-6,801,074 | -5.02 % | $-4,808,814 | | | | | | News Article | History of Axa Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barclays Plc | Institution | 20,907 | Sold Some | -44,354 | -67.96 % | $848,406 | $805,756 | $-42,650 | -5.02 % | $90,482 | | | | | | News Article | History of Barclays Plc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bnp Paribas Arbitrage Sa | Institution | 122,116 | Added More | 45,498 | 59.38 % | $4,955,467 | $4,706,351 | $-249,117 | -5.02 % | $-92,816 | | | | | | News Article | History of Bnp Paribas Arbitrage Sa Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bnp Paribas Asset Management S A S | Institution | 6,341 | Added More | 261 | 4.29 % | $257,318 | $244,382 | $-12,936 | -5.02 % | $-532 | | | | | | News Article | History of Bnp Paribas Asset Management S A S Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Caisse De Depot Et Placement Du Quebec | Institution | 1,513,864 | No Change | 0 | 0 % | $61,432,601 | $58,344,319 | $-3,088,283 | -5.02 % | $0 | | | | | | News Article | History of Caisse De Depot Et Placement Du Quebec Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Capital Fund Management S A | Institution | 622 | New Holding | 622 | 100 % | $25,241 | $23,972 | $-1,269 | -5.02 % | $-1,269 | | | | | | News Article | History of Capital Fund Management S A Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Capital One Financial Corp | Institution | | Sold All | -40 | -100 % | | | | -5.02 % | $82 | | | | | | News Article | History of Capital One Financial Corp Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Caxton Associates Llc | Institution | 28,175 | New Holding | 28,175 | 100 % | $1,143,342 | $1,085,865 | $-57,477 | -5.02 % | $-57,477 | | | | | | News Article | History of Caxton Associates Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Clearbridge Advisors Llc | Institution | 6,960,887 | Sold Some | -466,026 | -6.27 % | $282,472,794 | $268,272,585 | $-14,200,209 | -5.02 % | $950,693 | | | | | | News Article | History of Clearbridge Advisors Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Credit Agricole S A | Institution | 31,915 | Added More | 480 | 1.52 % | $1,295,111 | $1,230,004 | $-65,107 | -5.02 % | $-979 | | | | | | News Article | History of Credit Agricole S A Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Dekabank Deutsche Girozentrale | No Data | 210,405 | Added More | 1,105 | 0.52 % | $8,538,235 | $8,109,009 | $-429,226 | -5.02 % | $-2,254 | | | | | | News Article | History of Dekabank Deutsche Girozentrale Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Delaware Management Business Trust | Institution | 300,416 | Added More | 280,147 | 1382.14 % | $12,190,881 | $11,578,033 | $-612,849 | -5.02 % | $-571,500 | | | | | | News Article | History of Delaware Management Business Trust Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Denver Investment Advisors Llc | Institution | 317,135 | Sold Some | -166,245 | -34.39 % | $12,869,338 | $12,222,383 | $-646,955 | -5.02 % | $339,140 | | | | | | News Article | History of Denver Investment Advisors Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Dnb Asset Management Us Inc | Institution | 14,840 | Sold Some | -19,211 | -56.41 % | $602,207 | $571,934 | $-30,274 | -5.02 % | $39,190 | | | | | | News Article | History of Dnb Asset Management Us Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Fortaleza Asset Management Inc | Institution | 750 | No Change | 0 | 0 % | $30,435 | $28,905 | $-1,530 | -5.02 % | $0 | | | | | | News Article | History of Fortaleza Asset Management Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Gartmore Mutual Fund Capital Trust | Institution | 18,147 | Sold Some | -405,673 | -95.71 % | $736,405 | $699,385 | $-37,020 | -5.02 % | $827,573 | | | | | | News Article | History of Gartmore Mutual Fund Capital Trust Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geode Capital Management Llc | Institution | 404,498 | Added More | 33,059 | 8.90 % | $16,414,529 | $15,589,353 | $-825,176 | -5.02 % | $-67,440 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 208,115 | Sold Some | -144,609 | -40.99 % | $8,445,307 | $8,020,752 | $-424,555 | -5.02 % | $295,002 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Grantham Mayo Van Otterloo And Co Llc | Institution | 97,300 | Sold Some | -10,700 | -9.90 % | $3,948,434 | $3,749,942 | $-198,492 | -5.02 % | $21,828 | | | | | | News Article | History of Grantham Mayo Van Otterloo And Co Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Hambrecht And Quist Capital Management Llc | Institution | 271,347 | Sold Some | -139,653 | -33.97 % | $11,011,261 | $10,457,713 | $-553,548 | -5.02 % | $284,892 | | | | | | News Article | History of Hambrecht And Quist Capital Management Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Henderson Group Plc | Institution | 29,743 | No Change | 0 | 0 % | $1,206,971 | $1,146,295 | $-60,676 | -5.02 % | $0 | | | | | | News Article | History of Henderson Group Plc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Jennison Associates Llc | Institution | 7,115,808 | Added More | 1,797,989 | 33.81 % | $288,759,489 | $274,243,240 | $-14,516,248 | -5.02 % | $-3,667,898 | | | | | | News Article | History of Jennison Associates Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Knight Capital Group Inc | Institution | 5,989 | New Holding | 5,989 | 100 % | $243,034 | $230,816 | $-12,218 | -5.02 % | $-12,218 | | | | | | News Article | History of Knight Capital Group Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Labranche And Co Inc | Institution | 7,958 | Added More | 2,002 | 33.61 % | $322,936 | $306,701 | $-16,234 | -5.02 % | $-4,084 | | | | | | News Article | History of Labranche And Co Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Legg Mason Trust Company National Association | Institution | 1,000 | No Change | 0 | 0 % | $40,580 | $38,540 | $-2,040 | -5.02 % | $0 | | | | | | News Article | History of Legg Mason Trust Company National Association Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Lord Abbett And Co Llc | Institution | 316,016 | Sold Some | -23,836 | -7.01 % | $12,823,929 | $12,179,257 | $-644,673 | -5.02 % | $48,625 | | | | | | News Article | History of Lord Abbett And Co Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Los Angeles Capital Management And Equity Research Inc | Institution | 56,695 | New Holding | 56,695 | 100 % | $2,300,683 | $2,185,025 | $-115,658 | -5.02 % | $-115,658 | | | | | | News Article | History of Los Angeles Capital Management And Equity Research Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Managed Account Advisors Llc | Institution | 55,518 | Added More | 2,577 | 4.86 % | $2,252,920 | $2,139,664 | $-113,257 | -5.02 % | $-5,257 | | | | | | News Article | History of Managed Account Advisors Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | N-Q | Managers Funds - Managers Amg Essex Large Cap Growth Fund | Large-Cap Growth | 5,195 | No Change | 0 | 0 % | $210,813 | $200,215 | $-10,598 | -5.02 % | $0 | | | | | | News Article | History of Managers Funds - Managers Amg Essex Large Cap Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Marshall Ilsley Corp | Institution | 13,992 | Sold Some | -2,230 | -13.74 % | $567,795 | $539,252 | $-28,544 | -5.02 % | $4,549 | | | | | | News Article | History of Marshall Ilsley Corp Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Martingale Asset Management L P | Institution | 20,712 | Sold Some | -13,419 | -39.31 % | $840,493 | $798,240 | $-42,252 | -5.02 % | $27,375 | | | | | | News Article | History of Martingale Asset Management L P Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Mason Street Advisors Llc | Institution | 125,735 | Added More | 2,200 | 1.78 % | $5,102,326 | $4,845,827 | $-256,499 | -5.02 % | $-4,488 | | | | | | News Article | History of Mason Street Advisors Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | N-Q | Met Investors Series Trust - Janus Forty Portfolio | Specialty & Misc | 291,825 | No Change | 0 | 0 % | $11,842,259 | $11,246,936 | $-595,323 | -5.02 % | $0 | | | | | | News Article | History of Met Investors Series Trust - Janus Forty Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | N-Q | Met Investors Series Trust - Lazard Mid Cap Portfolio | Mid-Cap Core | 207,000 | No Change | 0 | 0 % | $8,400,060 | $7,977,780 | $-422,280 | -5.02 % | $0 | | | | | | News Article | History of Met Investors Series Trust - Lazard Mid Cap Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | N-Q | Met Investors Series Trust - Legg Mason Partners Aggressive Growth Portfolio | Multi-Cap Growth | 216,700 | Added More | 50,000 | 29.99 % | $8,793,686 | $8,351,618 | $-442,068 | -5.02 % | $-102,000 | | | | | | News Article | History of Met Investors Series Trust - Legg Mason Partners Aggressive Growth Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | N-Q | Met Investors Series Trust - Oppenheimer Capital Appreciation Portfolio | Specialty & Misc | 90,080 | Sold Some | -6,210 | -6.44 % | $3,655,446 | $3,471,683 | $-183,763 | -5.02 % | $12,668 | | | | | | News Article | History of Met Investors Series Trust - Oppenheimer Capital Appreciation Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | N-Q | Met Investors Series Trust - Turner Mid Cap Growth Portfolio | Mid-Cap Growth | 59,860 | New Holding | 59,860 | 100 % | $2,429,119 | $2,307,004 | $-122,114 | -5.02 % | $-122,114 | | | | | | News Article | History of Met Investors Series Trust - Turner Mid Cap Growth Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR/A | Neuberger Berman Group Llc | No Data | 473,813 | Added More | 46,479 | 10.87 % | $19,227,332 | $18,260,753 | $-966,579 | -5.02 % | $-94,817 | | | | | | News Article | History of Neuberger Berman Group Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | New York State Common Retirement Fund | Institution | 814,975 | Added More | 56,375 | 7.43 % | $33,071,686 | $31,409,137 | $-1,662,549 | -5.02 % | $-115,005 | | | | | | News Article | History of New York State Common Retirement Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Panagora Asset Management Inc | Institution | 8,486 | Sold Some | -1,407 | -14.22 % | $344,362 | $327,050 | $-17,311 | -5.02 % | $2,870 | | | | | | News Article | History of Panagora Asset Management Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Price T Rowe Associates Inc | Institution | 7,569,105 | Sold Some | -24,000 | -0.31 % | $307,154,281 | $291,713,307 | $-15,440,974 | -5.02 % | $48,960 | | | | | | News Article | History of Price T Rowe Associates Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 13,779 | Added More | 4,684 | 51.50 % | $559,152 | $531,043 | $-28,109 | -5.02 % | $-9,555 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Private Counsel Inc | Institution | | Sold All | -295 | -100 % | | | | -5.02 % | $602 | | | | | | News Article | History of Rbc Private Counsel Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Sei Trust Co | Institution | 27,360 | Added More | 20,980 | 328.84 % | $1,110,269 | $1,054,454 | $-55,814 | -5.02 % | $-42,799 | | | | | | News Article | History of Sei Trust Co Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Stux Capital Management Llc | Institution | 5,400 | New Holding | 5,400 | 100 % | $219,132 | $208,116 | $-11,016 | -5.02 % | $-11,016 | | | | | | News Article | History of Stux Capital Management Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Toronto Dominion Bank | Institution | 34,000 | No Change | 0 | 0 % | $1,379,720 | $1,310,360 | $-69,360 | -5.02 % | $0 | | | | | | News Article | History of Toronto Dominion Bank Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 5,914,542 | Added More | 432,860 | 7.89 % | $240,012,114 | $227,946,449 | $-12,065,666 | -5.02 % | $-883,034 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Wagonhound Investments Lp | Institution | 8,576 | Added More | 2,686 | 45.60 % | $348,014 | $330,519 | $-17,495 | -5.02 % | $-5,479 | | | | | | News Article | History of Wagonhound Investments Lp Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Wolverine Asset Management Llc | Institution | 13,640 | Sold Some | -48,080 | -77.90 % | $553,511 | $525,686 | $-27,826 | -5.02 % | $98,083 | | | | | | News Article | History of Wolverine Asset Management Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-13 | 2009-06-30 | 13F-HR/A | Caisse De Depot Et Placement Du Quebec | Institution | 1,513,864 | Sold Some | -3,916 | -0.25 % | $61,432,601 | $58,344,319 | $-3,088,283 | -5.02 % | $7,989 | | | | | | News Article | History of Caisse De Depot Et Placement Du Quebec Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-10-30 | 13F-HR | Td Asset Management Inc | Institution | 813,042 | Sold Some | -55,175 | -6.35 % | $33,204,635 | $31,334,639 | $-1,869,997 | -5.63 % | $126,903 | | | | | | News Article | History of Td Asset Management Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Allianz Global Investors Of America L P | Institution | | Sold All | -7,500 | -100 % | | | | -5.63 % | $17,250 | | | | | | News Article | History of Allianz Global Investors Of America L P Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Allstate Insurance Co | Institution | 29,218 | No Change | 0 | 0 % | $1,193,263 | $1,126,062 | $-67,201 | -5.63 % | $0 | | | | | | News Article | History of Allstate Insurance Co Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Allstate Retirement Plan | Institution | 5,484 | New Holding | 5,484 | 100 % | $223,967 | $211,353 | $-12,613 | -5.63 % | $-12,613 | | | | | | News Article | History of Allstate Retirement Plan Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Aviva Plc | Institution | 268,500 | New Holding | 268,500 | 100 % | $10,965,540 | $10,347,990 | $-617,550 | -5.63 % | $-617,550 | | | | | | News Article | History of Aviva Plc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Bank Of America Corp | Institution | 1,333,779 | Added More | 95,698 | 7.72 % | $54,471,534 | $51,403,843 | $-3,067,692 | -5.63 % | $-220,105 | | | | | | News Article | History of Bank Of America Corp Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 9,601,669 | Added More | 667,986 | 7.47 % | $392,132,162 | $370,048,323 | $-22,083,839 | -5.63 % | $-1,536,368 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 9,601,669 | Added More | 776,029 | 8.79 % | $392,132,162 | $370,048,323 | $-22,083,839 | -5.63 % | $-1,784,867 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Canada Pension Plan Investment Board | Institution | 1,600 | No Change | 0 | 0 % | $65,344 | $61,664 | $-3,680 | -5.63 % | $0 | | | | | | News Article | History of Canada Pension Plan Investment Board Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Chicago Equity Partners Llc | Institution | | Sold All | -55,800 | -100 % | | | | -5.63 % | $128,340 | | | | | | News Article | History of Chicago Equity Partners Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Claymore Advisors Llc | Institution | 6,109 | Sold Some | -2,586 | -29.74 % | $249,492 | $235,441 | $-14,051 | -5.63 % | $5,948 | | | | | | News Article | History of Claymore Advisors Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Cookson Peirce And Co Inc | Institution | 64,610 | Sold Some | -2,560 | -3.81 % | $2,638,672 | $2,490,069 | $-148,603 | -5.63 % | $5,888 | | | | | | News Article | History of Cookson Peirce And Co Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Credit Suisse | Institution | 111,563 | New Holding | 111,563 | 100 % | $4,556,233 | $4,299,638 | $-256,595 | -5.63 % | $-256,595 | | | | | | News Article | History of Credit Suisse Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Davidson D A And Co | Institution | 5,977 | Added More | 110 | 1.87 % | $244,101 | $230,354 | $-13,747 | -5.63 % | $-253 | | | | | | News Article | History of Davidson D A And Co Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Davidson Investment Advisors | Institution | 5,977 | New Holding | 5,977 | 100 % | $244,101 | $230,354 | $-13,747 | -5.63 % | $-13,747 | | | | | | News Article | History of Davidson Investment Advisors Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | First Quadrant L P | Institution | 69,900 | Added More | 61,400 | 722.35 % | $2,854,716 | $2,693,946 | $-160,770 | -5.63 % | $-141,220 | | | | | | News Article | History of First Quadrant L P Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | First Trust Advisors Lp | Institution | 84,046 | Sold Some | -24,953 | -22.89 % | $3,432,439 | $3,239,133 | $-193,306 | -5.63 % | $57,392 | | | | | | News Article | History of First Trust Advisors Lp Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Fortis Investments Management Usa Inc | Institution | 137,324 | No Change | 0 | 0 % | $5,608,312 | $5,292,467 | $-315,845 | -5.63 % | $0 | | | | | | News Article | History of Fortis Investments Management Usa Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Franklin Resources Inc | Institution | 284,200 | No Change | 0 | 0 % | $11,606,728 | $10,953,068 | $-653,660 | -5.63 % | $0 | | | | | | News Article | History of Franklin Resources Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Ing Investment Management Co | Institution | 199,350 | Added More | 2,200 | 1.11 % | $8,141,454 | $7,682,949 | $-458,505 | -5.63 % | $-5,060 | | | | | | News Article | History of Ing Investment Management Co Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Irish Life Investment Managers | Institution | 1,274 | No Change | 0 | 0 % | $52,030 | $49,100 | $-2,930 | -5.63 % | $0 | | | | | | News Article | History of Irish Life Investment Managers Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Kbc Group Nv | Institution | 61,222 | Added More | 1,781 | 2.99 % | $2,500,306 | $2,359,496 | $-140,811 | -5.63 % | $-4,096 | | | | | | News Article | History of Kbc Group Nv Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Korea Investment Corp | No Data | | Sold All | -46,236 | -100 % | | | | -5.63 % | $106,343 | | | | | | News Article | History of Korea Investment Corp Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Legal And General Group Plc | Institution | 5,288 | Added More | 1,588 | 42.91 % | $215,962 | $203,800 | $-12,162 | -5.63 % | $-3,652 | | | | | | News Article | History of Legal And General Group Plc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 81,029 | Sold Some | -207,486 | -71.91 % | $3,309,224 | $3,122,858 | $-186,367 | -5.63 % | $477,218 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mfc Global Investment Management Usa Ltd | Institution | 321,530 | Added More | 16,362 | 5.36 % | $13,131,285 | $12,391,766 | $-739,519 | -5.63 % | $-37,633 | | | | | | News Article | History of Mfc Global Investment Management Usa Ltd Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Nomura Asset Management Co Ltd | Institution | 545,907 | Added More | 47,207 | 9.46 % | $22,294,842 | $21,039,256 | $-1,255,586 | -5.63 % | $-108,576 | | | | | | News Article | History of Nomura Asset Management Co Ltd Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Ii Inc | Institution | 51,596 | Added More | 2,865 | 5.87 % | $2,107,181 | $1,988,510 | $-118,671 | -5.63 % | $-6,590 | | | | | | News Article | History of Padco Advisors Ii Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Inc | Institution | 295,077 | Added More | 71,664 | 32.07 % | $12,050,945 | $11,372,268 | $-678,677 | -5.63 % | $-164,827 | | | | | | News Article | History of Padco Advisors Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Principal Financial Group Inc | Institution | 207,171 | Added More | 14,072 | 7.28 % | $8,460,864 | $7,984,370 | $-476,493 | -5.63 % | $-32,366 | | | | | | News Article | History of Principal Financial Group Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Royal Bank Of Scotland Group Plc | Institution | 68,307 | Added More | 45,283 | 196.67 % | $2,789,658 | $2,632,552 | $-157,106 | -5.63 % | $-104,151 | | | | | | News Article | History of Royal Bank Of Scotland Group Plc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Rs Investment Management Co Llc | Institution | 20,000 | New Holding | 20,000 | 100 % | $816,800 | $770,800 | $-46,000 | -5.63 % | $-46,000 | | | | | | News Article | History of Rs Investment Management Co Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Russell Frank Co | Institution | 152,263 | Added More | 27,300 | 21.84 % | $6,218,421 | $5,868,216 | $-350,205 | -5.63 % | $-62,790 | | | | | | News Article | History of Russell Frank Co Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Sands Capital Management Llc | Institution | 82,000 | Added More | 1,200 | 1.48 % | $3,348,880 | $3,160,280 | $-188,600 | -5.63 % | $-2,760 | | | | | | News Article | History of Sands Capital Management Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Santa Barbara Asset Management | Institution | 800 | No Change | 0 | 0 % | $32,672 | $30,832 | $-1,840 | -5.63 % | $0 | | | | | | News Article | History of Santa Barbara Asset Management Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Sovereign Asset Management Corp | Institution | 7,896 | Added More | 4,256 | 116.92 % | $322,473 | $304,312 | $-18,161 | -5.63 % | $-9,789 | | | | | | News Article | History of Sovereign Asset Management Corp Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | 194,853 | Added More | 102,861 | 111.81 % | $7,957,797 | $7,509,635 | $-448,162 | -5.63 % | $-236,580 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Tewksbury Capital Management Ltd | Institution | | Sold All | -16,351 | -100 % | | | | -5.63 % | $37,607 | | | | | | News Article | History of Tewksbury Capital Management Ltd Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | United Services Automobile Association | Institution | 38,332 | Sold Some | -4,418 | -10.33 % | $1,565,479 | $1,477,315 | $-88,164 | -5.63 % | $10,161 | | | | | | News Article | History of United Services Automobile Association Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Veritable L P | Institution | 11,608 | Sold Some | -123 | -1.04 % | $474,071 | $447,372 | $-26,698 | -5.63 % | $283 | | | | | | News Article | History of Veritable L P Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Wall Street Associates | Institution | 120,300 | Sold Some | -6,500 | -5.12 % | $4,913,052 | $4,636,362 | $-276,690 | -5.63 % | $14,950 | | | | | | News Article | History of Wall Street Associates Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Westfield Capital Management Co Llc | Institution | 1,685,710 | Sold Some | -591,047 | -25.96 % | $68,844,396 | $64,967,263 | $-3,877,133 | -5.63 % | $1,359,408 | | | | | | News Article | History of Westfield Capital Management Co Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | World Asset Management Inc | Institution | 29,673 | Added More | 10,007 | 50.88 % | $1,211,845 | $1,143,597 | $-68,248 | -5.63 % | $-23,016 | | | | | | News Article | History of World Asset Management Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Wyper Partners Llc | Institution | 89,809 | Sold Some | -153,826 | -63.13 % | $3,667,800 | $3,461,239 | $-206,561 | -5.63 % | $353,800 | | | | | | News Article | History of Wyper Partners Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | American Century Companies Inc | Institution | 518,396 | Sold Some | -150,900 | -22.54 % | $21,093,533 | $19,978,982 | $-1,114,551 | -5.28 % | $324,435 | | | | | | News Article | History of American Century Companies Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Aperio Group Llc | Institution | 8,461 | Added More | 768 | 9.98 % | $344,278 | $326,087 | $-18,191 | -5.28 % | $-1,651 | | | | | | News Article | History of Aperio Group Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Citigroup Inc | Institution | 263,630 | Sold Some | -340,783 | -56.38 % | $10,727,105 | $10,160,300 | $-566,805 | -5.28 % | $732,683 | | | | | | News Article | History of Citigroup Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Comerica Bank | Institution | 157,349 | Added More | 15,332 | 10.79 % | $6,402,531 | $6,064,230 | $-338,300 | -5.28 % | $-32,964 | | | | | | News Article | History of Comerica Bank Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Dai Ichi Mutual Life Insurance Co | Institution | 4,052 | No Change | 0 | 0 % | $164,876 | $156,164 | $-8,712 | -5.28 % | $0 | | | | | | News Article | History of Dai Ichi Mutual Life Insurance Co Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Dlibj Asset Management Co Ltd | Institution | 27,266 | Added More | 3,289 | 13.71 % | $1,109,454 | $1,050,832 | $-58,622 | -5.28 % | $-7,071 | | | | | | News Article | History of Dlibj Asset Management Co Ltd Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Glenmede Trust Co Na | Institution | 900 | Sold Some | -500 | -35.71 % | $36,621 | $34,686 | $-1,935 | -5.28 % | $1,075 | | | | | | News Article | History of Glenmede Trust Co Na Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Imc-Chicago Llc | No Data | | Sold All | -1,019 | -100 % | | | | -5.28 % | $2,191 | | | | | | News Article | History of Imc-Chicago Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | J P Morgan Chase And Co | Institution | 232,186 | Sold Some | -25,414 | -9.86 % | $9,447,648 | $8,948,448 | $-499,200 | -5.28 % | $54,640 | | | | | | News Article | History of J P Morgan Chase And Co Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Sectoral Asset Management Inc | Institution | 2,397,188 | Added More | 11,834 | 0.49 % | $97,541,580 | $92,387,626 | $-5,153,954 | -5.28 % | $-25,443 | | | | | | News Article | History of Sectoral Asset Management Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Tesseract Capital Llc | No Data | | Sold All | -240 | -100 % | | | | -5.28 % | $516 | | | | | | News Article | History of Tesseract Capital Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 208,293 | Sold Some | -51,607 | -19.85 % | $8,475,442 | $8,027,612 | $-447,830 | -5.28 % | $110,955 | | | | | | News Article | History of Ubs Ag Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Verizon Communications Inc | Institution | 16,056 | No Change | 0 | 0 % | $653,319 | $618,798 | $-34,520 | -5.28 % | $0 | | | | | | News Article | History of Verizon Communications Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-10 | 2009-06-30 | 13F-HR/A | Dlibj Asset Management Co Ltd | Institution | 23,977 | Added More | 416 | 1.76 % | $975,624 | $924,074 | $-51,551 | -5.28 % | $-894 | | | | | | News Article | History of Dlibj Asset Management Co Ltd Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-10 | 2009-03-31 | 13F-HR/A | Dlibj Asset Management Co Ltd | Institution | 23,561 | Added More | 6,050 | 34.54 % | $958,697 | $908,041 | $-50,656 | -5.28 % | $-13,008 | | | | | | News Article | History of Dlibj Asset Management Co Ltd Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-10 | 2008-12-31 | 13F-HR/A | Dlibj Asset Management Co Ltd | Institution | 17,511 | No Change | 0 | 0 % | $712,523 | $674,874 | $-37,649 | -5.28 % | $0 | | | | | | News Article | History of Dlibj Asset Management Co Ltd Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Aberdeen Asset Management Plc | Institution | 47,101 | New Holding | 47,101 | 100 % | $1,883,569 | $1,815,273 | $-68,296 | -3.62 % | $-68,296 | | | | | | News Article | History of Aberdeen Asset Management Plc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Ccm Partners | Institution | 26,360 | Added More | 1,117 | 4.42 % | $1,054,136 | $1,015,914 | $-38,222 | -3.62 % | $-1,620 | | | | | | News Article | History of Ccm Partners Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Fan Asset Management Llc | Institution | 15,800 | No Change | 0 | 0 % | $631,842 | $608,932 | $-22,910 | -3.62 % | $0 | | | | | | News Article | History of Fan Asset Management Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Federated Investors Inc | Institution | 94,300 | Added More | 1,500 | 1.61 % | $3,771,057 | $3,634,322 | $-136,735 | -3.62 % | $-2,175 | | | | | | News Article | History of Federated Investors Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Johnson Investment Counsel Inc | Institution | 15,575 | Added More | 685 | 4.60 % | $622,844 | $600,261 | $-22,584 | -3.62 % | $-993 | | | | | | News Article | History of Johnson Investment Counsel Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Numeric Investors Llc | Institution | | Sold All | -37,800 | -100 % | | | | -3.62 % | $54,810 | | | | | | News Article | History of Numeric Investors Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | State Of Wisconsin Investment Board | Institution | 290,745 | Sold Some | -5,280 | -1.78 % | $11,626,893 | $11,205,312 | $-421,580 | -3.62 % | $7,656 | | | | | | News Article | History of State Of Wisconsin Investment Board Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Twin Capital Management Inc | Institution | 41,450 | Added More | 150 | 0.36 % | $1,657,586 | $1,597,483 | $-60,103 | -3.62 % | $-218 | | | | | | News Article | History of Twin Capital Management Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Vtl Associates Llc | Institution | | Sold All | -12 | -100 % | | | | -3.62 % | $17 | | | | | | News Article | History of Vtl Associates Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-09 | 2009-08-31 | N-CSR | Consulting Group Capital Markets Funds - Small Capitalization Growth Investments | Small-Cap Growth | 68,150 | Sold Some | -63,350 | -48.17 % | $2,725,319 | $2,626,501 | $-98,818 | -3.62 % | $91,858 | | | | | | News Article | History of Consulting Group Capital Markets Funds - Small Capitalization Growth Investments Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Blair William And Co | Institution | 6,755 | Sold Some | -5,235 | -43.66 % | $264,931 | $260,338 | $-4,593 | -1.73 % | $3,560 | | | | | | News Article | History of Blair William And Co Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Condor Capital Management | Institution | 5,925 | No Change | 0 | 0 % | $232,379 | $228,350 | $-4,029 | -1.73 % | $0 | | | | | | News Article | History of Condor Capital Management Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Copper Rock Capital Partners Llc | Institution | 184,083 | Sold Some | -147,987 | -44.56 % | $7,219,735 | $7,094,559 | $-125,176 | -1.73 % | $100,631 | | | | | | News Article | History of Copper Rock Capital Partners Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Genworth Financial Inc | Institution | 34 | New Holding | 34 | 100 % | $1,333 | $1,310 | $-23 | -1.73 % | $-23 | | | | | | News Article | History of Genworth Financial Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Hartford Investment Management Co | Institution | 26,707 | Added More | 1,390 | 5.49 % | $1,047,449 | $1,029,288 | $-18,161 | -1.73 % | $-945 | | | | | | News Article | History of Hartford Investment Management Co Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metropolitan Life Insurance Co | Institution | 88,327 | Added More | 4,797 | 5.74 % | $3,464,185 | $3,404,123 | $-60,062 | -1.73 % | $-3,262 | | | | | | News Article | History of Metropolitan Life Insurance Co Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pioneer Investment Management Inc | Institution | 826,248 | Added More | 7,376 | 0.90 % | $32,405,447 | $31,843,598 | $-561,849 | -1.73 % | $-5,016 | | | | | | News Article | History of Pioneer Investment Management Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pnc Financial Services Group Inc | Institution | 931 | Sold Some | -9,184 | -90.79 % | $36,514 | $35,881 | $-633 | -1.73 % | $6,245 | | | | | | News Article | History of Pnc Financial Services Group Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Schwab Charles Investment Management Inc | Institution | 85,456 | Added More | 3,000 | 3.63 % | $3,351,584 | $3,293,474 | $-58,110 | -1.73 % | $-2,040 | | | | | | News Article | History of Schwab Charles Investment Management Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tcw Group Inc | Institution | 1,387,323 | Added More | 73,137 | 5.56 % | $54,410,808 | $53,467,428 | $-943,380 | -1.73 % | $-49,733 | | | | | | News Article | History of Tcw Group Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Teachers Advisors Inc | Institution | 236,447 | Added More | 112,345 | 90.52 % | $9,273,451 | $9,112,667 | $-160,784 | -1.73 % | $-76,395 | | | | | | News Article | History of Teachers Advisors Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tiaa Cref Investment Management Llc | Institution | 1,172,552 | Added More | 12,551 | 1.08 % | $45,987,489 | $45,190,154 | $-797,335 | -1.73 % | $-8,535 | | | | | | News Article | History of Tiaa Cref Investment Management Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Trilogy Global Advisors Llc | Institution | 2,075,832 | Sold Some | -255,039 | -10.94 % | $81,414,131 | $80,002,565 | $-1,411,566 | -1.73 % | $173,427 | | | | | | News Article | History of Trilogy Global Advisors Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Waddell And Reed Financial Inc | Institution | 2,273,000 | Added More | 819,625 | 56.39 % | $89,147,060 | $87,601,420 | $-1,545,640 | -1.73 % | $-557,345 | | | | | | News Article | History of Waddell And Reed Financial Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-06 | 2009-08-31 | N-CSR | John Hancock Funds Ii - Capital Appreciation Fund | Large-Cap Growth | 209,200 | Added More | 56,900 | 37.36 % | $8,204,824 | $8,062,568 | $-142,256 | -1.73 % | $-38,692 | | | | | | News Article | History of John Hancock Funds Ii - Capital Appreciation Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-06 | 2009-06-30 | 13F-HR | Condor Capital Management | Institution | 5,925 | New Holding | 5,925 | 100 % | $232,379 | $228,350 | $-4,029 | -1.73 % | $-4,029 | | | | | | News Article | History of Condor Capital Management Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Aureus Asset Management Llc | Institution | 5,000 | No Change | 0 | 0 % | $193,700 | $192,700 | $-1,000 | -0.51 % | $0 | | | | | | News Article | History of Aureus Asset Management Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Bank Of Hawaii | Institution | | Sold All | -2,525 | -100 % | | | | -0.51 % | $505 | | | | | | News Article | History of Bank Of Hawaii Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Fixed Income Securities Lp | Institution | 10,726 | Added More | 2,378 | 28.48 % | $415,525 | $413,380 | $-2,145 | -0.51 % | $-476 | | | | | | News Article | History of Fixed Income Securities Lp Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Mitsubishi Ufj Asset Management Co Ltd | No Data | 45,500 | Sold Some | -4,600 | -9.18 % | $1,762,670 | $1,753,570 | $-9,100 | -0.51 % | $920 | | | | | | News Article | History of Mitsubishi Ufj Asset Management Co Ltd Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Nisa Investment Advisors L L C | Institution | 60,400 | Added More | 1,300 | 2.19 % | $2,339,896 | $2,327,816 | $-12,080 | -0.51 % | $-260 | | | | | | News Article | History of Nisa Investment Advisors L L C Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Old Mutual Asset Managers Uk Ltd | Institution | 162,700 | Added More | 12,357 | 8.21 % | $6,302,998 | $6,270,458 | $-32,540 | -0.51 % | $-2,471 | | | | | | News Article | History of Old Mutual Asset Managers Uk Ltd Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Parametric Portfolio Associates | Institution | 144,582 | Added More | 4,449 | 3.17 % | $5,601,107 | $5,572,190 | $-28,916 | -0.51 % | $-890 | | | | | | News Article | History of Parametric Portfolio Associates Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Profund Advisors Llc | Institution | 81,820 | Added More | 10,882 | 15.34 % | $3,169,707 | $3,153,343 | $-16,364 | -0.51 % | $-2,176 | | | | | | News Article | History of Profund Advisors Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Proshare Advisors Llc | Institution | 114,133 | Sold Some | -44,081 | -27.86 % | $4,421,512 | $4,398,686 | $-22,827 | -0.51 % | $8,816 | | | | | | News Article | History of Proshare Advisors Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Roosevelt Investment Group Inc | Institution | | Sold All | -45 | -100 % | | | | -0.51 % | $9 | | | | | | News Article | History of Roosevelt Investment Group Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Tal Global Asset Management Inc | Institution | 6,892 | No Change | 0 | 0 % | $266,996 | $265,618 | $-1,378 | -0.51 % | $0 | | | | | | News Article | History of Tal Global Asset Management Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Teacher Retirement System Of Texas | Institution | 258,474 | Sold Some | -1,937 | -0.74 % | $10,013,283 | $9,961,588 | $-51,695 | -0.51 % | $387 | | | | | | News Article | History of Teacher Retirement System Of Texas Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-05 | 2009-08-31 | N-CSR | Claymore Exchange Traded Fund Trust - Claymoreocean Tomo Growth Etf | Multi-Cap Growth | 348 | Added More | 60 | 20.83 % | $13,482 | $13,412 | $-70 | -0.51 % | $-12 | | | | | | News Article | History of Claymore Exchange Traded Fund Trust - Claymoreocean Tomo Growth Etf Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-05 | 2009-08-31 | N-CSR | Claymore Exchange Traded Fund Trust - Claymoreocean Tomo Patent Etf | Specialty & Misc | 191 | No Change | 0 | 0 % | $7,399 | $7,361 | $-38 | -0.51 % | $0 | | | | | | News Article | History of Claymore Exchange Traded Fund Trust - Claymoreocean Tomo Patent Etf Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-05 | 2009-08-31 | N-CSR | Claymore Exchange Traded Fund Trust - Zacks Sector Rotation | Specialty & Misc | 6,625 | New Holding | 6,625 | 100 % | $256,653 | $255,328 | $-1,325 | -0.51 % | $-1,325 | | | | | | News Article | History of Claymore Exchange Traded Fund Trust - Zacks Sector Rotation Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Geewax Plus Partners Llc | Institution | 3,500 | Added More | 3,300 | 1650.00 % | $129,115 | $134,890 | $5,775 | 4.47 % | $5,445 | | | | | | News Article | History of Geewax Plus Partners Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Gw Capital Management Incco | Institution | 226,488 | Added More | 80,282 | 54.91 % | $8,355,142 | $8,728,848 | $373,705 | 4.47 % | $132,465 | | | | | | News Article | History of Gw Capital Management Incco Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Mitsubishi Ufj Trust Banking Corp | No Data | 146,951 | Added More | 6,926 | 4.94 % | $5,421,022 | $5,663,492 | $242,469 | 4.47 % | $11,428 | | | | | | News Article | History of Mitsubishi Ufj Trust Banking Corp Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Tradeworx Inc | Institution | 26,626 | Added More | 8,299 | 45.28 % | $982,233 | $1,026,166 | $43,933 | 4.47 % | $13,693 | | | | | | News Article | History of Tradeworx Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Washington Capital Management Inc | Institution | 28,200 | New Holding | 28,200 | 100 % | $1,040,298 | $1,086,828 | $46,530 | 4.47 % | $46,530 | | | | | | News Article | History of Washington Capital Management Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-04 | 2009-08-31 | N-CSR | Alliancebernstein Portfolios - Alliancebernstein Growth Fund | Multi-Cap Growth | 152,700 | Added More | 86,300 | 129.96 % | $5,633,103 | $5,885,058 | $251,955 | 4.47 % | $142,395 | | | | | | News Article | History of Alliancebernstein Portfolios - Alliancebernstein Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-04 | 2009-08-31 | N-CSRS | Gmo Trust - Gmo Value Fund | Multi-Cap Value | | Sold All | -51,700 | -100 % | | | | 4.47 % | $-85,305 | | | | | | News Article | History of Gmo Trust - Gmo Value Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-04 | 2009-08-31 | N-CSR | Legg Mason Partners Equity Trust - Legg Mason Partners Aggressive Growth Fund | Multi-Cap Growth | 1,683,140 | New Holding | 1,683,140 | 100 % | $62,091,035 | $64,868,216 | $2,777,181 | 4.47 % | $2,777,181 | | | | | | News Article | History of Legg Mason Partners Equity Trust - Legg Mason Partners Aggressive Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Apg All Pensions Group | Institution | 15,460 | Sold Some | -8,455 | -35.35 % | $570,629 | $595,828 | $25,200 | 4.41 % | $-13,782 | | | | | | News Article | History of Apg All Pensions Group Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Cannell Peter B And Co Inc | Institution | 1,073,590 | Added More | 83,445 | 8.42 % | $39,626,207 | $41,376,159 | $1,749,952 | 4.41 % | $136,015 | | | | | | News Article | History of Cannell Peter B And Co Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR/A | Cohen Klingenstein Llc | No Data | 16,835 | No Change | 0 | 0 % | $621,380 | $648,821 | $27,441 | 4.41 % | $0 | | | | | | News Article | History of Cohen Klingenstein Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Gme Capital Llc | Institution | 54,800 | No Change | 0 | 0 % | $2,022,668 | $2,111,992 | $89,324 | 4.41 % | $0 | | | | | | News Article | History of Gme Capital Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Private Trust Co Na | Institution | | Sold All | -165 | -100 % | | | | 4.41 % | $-269 | | | | | | News Article | History of Private Trust Co Na Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Prudential Financial Inc | Institution | 109,605 | Added More | 5,240 | 5.02 % | $4,045,521 | $4,224,177 | $178,656 | 4.41 % | $8,541 | | | | | | News Article | History of Prudential Financial Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Turner Investment Partners Inc | Institution | 467,652 | New Holding | 467,652 | 100 % | $17,261,035 | $18,023,308 | $762,273 | 4.41 % | $762,273 | | | | | | News Article | History of Turner Investment Partners Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-03 | 2009-08-31 | N-CSR | California Investment Trust - S And P Midcap Index Fund | Mid-Cap Core | 24,403 | Added More | 1,117 | 4.79 % | $900,715 | $940,492 | $39,777 | 4.41 % | $1,821 | | | | | | News Article | History of California Investment Trust - S And P Midcap Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-03 | 2009-08-31 | N-CSR | Mellon Funds Trust - Mellon Large Cap Stock Fund | Large-Cap Core | | Sold All | -545,450 | -100 % | | | | 4.41 % | $-889,084 | | | | | | News Article | History of Mellon Funds Trust - Mellon Large Cap Stock Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-03 | 2009-06-30 | 13F-HR/A | Cohen Klingenstein Llc | No Data | 16,835 | No Change | 0 | 0 % | $621,380 | $648,821 | $27,441 | 4.41 % | $0 | | | | | | News Article | History of Cohen Klingenstein Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Citizens Bank Wealth Management Na | Institution | 39 | New Holding | 39 | 100 % | $1,410 | $1,503 | $93 | 6.61 % | $93 | | | | | | News Article | History of Citizens Bank Wealth Management Na Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Ghp Investment Advisors Inc | Institution | | Sold All | -66 | -100 % | | | | 6.61 % | $-158 | | | | | | News Article | History of Ghp Investment Advisors Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-02 | 2009-09-30 | 13F-HR | Thrivent Financial For Lutherans | Institution | 1,073,320 | Sold Some | -1,413,020 | -56.83 % | $38,800,518 | $41,365,753 | $2,565,235 | 6.61 % | $-3,377,118 | | | | | | News Article | History of Thrivent Financial For Lutherans Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Pharmaceuticals Portfolio | Health/Biotech | | Sold All | -180 | -100 % | | | | 6.61 % | $-430 | | | | | | News Article | History of Fidelity Select Portfolios - Pharmaceuticals Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Technology Portfolio | Science & Tech | 1,473,504 | Added More | 240,600 | 19.51 % | $53,267,170 | $56,788,844 | $3,521,675 | 6.61 % | $575,034 | | | | | | News Article | History of Fidelity Select Portfolios - Technology Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | General Electric Co | Institution | 611,675 | Added More | 53 | 0.00 % | $20,527,813 | $23,573,955 | $3,046,142 | 14.83 % | $264 | | | | | | News Article | History of General Electric Co Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Texas Permanent School Fund | Institution | 290,190 | Added More | 9,243 | 3.28 % | $9,738,776 | $11,183,923 | $1,445,146 | 14.83 % | $46,030 | | | | | | News Article | History of Texas Permanent School Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Windward Investment Management Inc | Institution | 44,815 | No Change | 0 | 0 % | $1,503,991 | $1,727,170 | $223,179 | 14.83 % | $0 | | | | | | News Article | History of Windward Investment Management Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Advisor Series I - Balanced Fund | Mixed-Asset Target Allocation Moderate | 115,300 | New Holding | 115,300 | 100 % | $3,869,468 | $4,443,662 | $574,194 | 14.83 % | $574,194 | | | | | | News Article | History of Fidelity Advisor Series I - Balanced Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Advisor Series I - Growth Opportunities Fund | Large-Cap Core | 349,000 | Sold Some | -270,200 | -43.63 % | $11,712,440 | $13,450,460 | $1,738,020 | 14.83 % | $-1,345,596 | | | | | | News Article | History of Fidelity Advisor Series I - Growth Opportunities Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Advisor Series I - Large Cap Fund | Large-Cap Core | 130,300 | Sold Some | -63,200 | -32.66 % | $4,372,868 | $5,021,762 | $648,894 | 14.83 % | $-314,736 | | | | | | News Article | History of Fidelity Advisor Series I - Large Cap Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Advisor Series I - Mid Cap Fund | Mid-Cap Core | 1,173,900 | No Change | 0 | 0 % | $39,396,084 | $45,242,106 | $5,846,022 | 14.83 % | $0 | | | | | | News Article | History of Fidelity Advisor Series I - Mid Cap Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock | Specialty & Misc | 6,816 | No Compare | | | $228,745 | $262,689 | $33,944 | 14.83 % | | | | | | | News Article | History of Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Financial Trust - Fidelity Independence Fund | Specialty & Misc | 900,000 | No Change | 0 | 0 % | $30,204,000 | $34,686,000 | $4,482,000 | 14.83 % | $0 | | | | | | News Article | History of Fidelity Financial Trust - Fidelity Independence Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Mt Vernon Street Trust - Fidelity Aggressive Growth Fund | Multi-Cap Growth | 809,887 | Added More | 321,387 | 65.79 % | $27,179,808 | $31,213,045 | $4,033,237 | 14.83 % | $1,600,507 | | | | | | News Article | History of Fidelity Mt Vernon Street Trust - Fidelity Aggressive Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Mt Vernon Street Trust - Fidelity Growth Company Fund | Multi-Cap Growth | | Sold All | -9,303,987 | -100 % | | | | 14.83 % | $-46,333,855 | | | | | | News Article | History of Fidelity Mt Vernon Street Trust - Fidelity Growth Company Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Securities Fund - Agressive Growth Fund | Global Small/Mid-Cap Growth | 12,238 | Sold Some | -552,762 | -97.83 % | $410,707 | $471,653 | $60,945 | 14.83 % | $-2,752,755 | | | | | | News Article | History of Fidelity Securities Fund - Agressive Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-CSR | Growth Fund Of America Inc - Growth Fund Of America Inc | Multi-Cap Growth | 11,253,000 | Added More | 925,000 | 8.95 % | $377,650,680 | $433,690,620 | $56,039,940 | 14.83 % | $4,606,500 | | | | | | News Article | History of Growth Fund Of America Inc - Growth Fund Of America Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-CSR | Jennison Blend Fund Inc - Jennison Blend Fund Inc | Specialty & Misc | | Sold All | -51,400 | -100 % | | | | 14.83 % | $-255,972 | | | | | | News Article | History of Jennison Blend Fund Inc - Jennison Blend Fund Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-CSR | Jennison Mid Cap Growth Fund Inc - Jennison U S Emerging Growth Fund Inc | Mid-Cap Growth | | Sold All | -204,000 | -100 % | | | | 14.83 % | $-1,015,920 | | | | | | News Article | History of Jennison Mid Cap Growth Fund Inc - Jennison U S Emerging Growth Fund Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Jennison Sector Funds Inc - Jennison Health Sciences Fund | Health/Biotech | 589,800 | New Holding | 589,800 | 100 % | $19,793,688 | $22,730,892 | $2,937,204 | 14.83 % | $2,937,204 | | | | | | News Article | History of Jennison Sector Funds Inc - Jennison Health Sciences Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Lord Abbett Research Fund Inc - Growth Opportunities Fund | Mid-Cap Growth | 106,978 | Added More | 49,038 | 84.63 % | $3,590,182 | $4,122,932 | $532,750 | 14.83 % | $244,209 | | | | | | News Article | History of Lord Abbett Research Fund Inc - Growth Opportunities Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Managers Amg Funds - Essex Growth Fund | Multi-Cap Growth | 2,921 | Added More | 139 | 4.99 % | $98,029 | $112,575 | $14,547 | 14.83 % | $692 | | | | | | News Article | History of Managers Amg Funds - Essex Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Pioneer Series Trust I - Pioneer Growth Fund | No Data | 44,000 | New Holding | 44,000 | 100 % | $1,476,640 | $1,695,760 | $219,120 | 14.83 % | $219,120 | | | | | | News Article | History of Pioneer Series Trust I - Pioneer Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Sei Institutional Investments Trust - Siit Large Cap Fund | Large-Cap Core | | Sold All | -5,000 | -100 % | | | | 14.83 % | $-24,900 | | | | | | News Article | History of Sei Institutional Investments Trust - Siit Large Cap Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-CSR | Vanguard World Fund - Vanguard Health Care Index Fund | Health/Biotech | 79,185 | New Holding | 79,185 | 100 % | $2,657,449 | $3,051,790 | $394,341 | 14.83 % | $394,341 | | | | | | News Article | History of Vanguard World Fund - Vanguard Health Care Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Biondo Investment Advisors Llc | No Data | 79,555 | New Holding | 79,555 | 100 % | $2,692,937 | $3,066,050 | $373,113 | 13.85 % | $373,113 | | | | | | News Article | History of Biondo Investment Advisors Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 93,500 | Added More | 1,900 | 2.07 % | $3,164,975 | $3,603,490 | $438,515 | 13.85 % | $8,911 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-CSRS | Dreyfus Growth Opportunity Fund Inc - Dreyfus Growth Opportunity Fund Inc | Large-Cap Growth | | Sold All | -26,110 | -100 % | | | | 13.85 % | $-122,456 | | | | | | News Article | History of Dreyfus Growth Opportunity Fund Inc - Dreyfus Growth Opportunity Fund Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Dreyfus Premier Manager Funds Ii - Balanced Opportunity Fund | Mixed-Asset Target Allocation Growth | 29,880 | Added More | 3,120 | 11.65 % | $1,011,438 | $1,151,575 | $140,137 | 13.85 % | $14,633 | | | | | | News Article | History of Dreyfus Premier Manager Funds Ii - Balanced Opportunity Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Evergreen Equity Trust De - Evergreen Market Index Growth Fund | Multi-Cap Growth | 15,517 | Sold Some | -425 | -2.66 % | $525,250 | $598,025 | $72,775 | 13.85 % | $-1,993 | | | | | | News Article | History of Evergreen Equity Trust De - Evergreen Market Index Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Forum Funds - Shaker Fund | Specialty & Misc | | Sold All | -5,800 | -100 % | | | | 13.85 % | $-27,202 | | | | | | News Article | History of Forum Funds - Shaker Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | New Economy Fund - New Economy Fund | Multi-Cap Growth | 1,350,000 | No Change | 0 | 0 % | $45,697,500 | $52,029,000 | $6,331,500 | 13.85 % | $0 | | | | | | News Article | History of New Economy Fund - New Economy Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Riversource Managers Series Inc - Riversource Aggressive Growth Fund | Mid-Cap Growth | 26,600 | New Holding | 26,600 | 100 % | $900,410 | $1,025,164 | $124,754 | 13.85 % | $124,754 | | | | | | News Article | History of Riversource Managers Series Inc - Riversource Aggressive Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Health Sciences Fund | Health/Biotech | 81,594 | New Holding | 81,594 | 100 % | $2,761,957 | $3,144,633 | $382,676 | 13.85 % | $382,676 | | | | | | News Article | History of Valic Co I - Health Sciences Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Small Cap Fund | Small-Cap Core | 8,011 | New Holding | 8,011 | 100 % | $271,172 | $308,744 | $37,572 | 13.85 % | $37,572 | | | | | | News Article | History of Valic Co I - Small Cap Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-28 | 2009-08-31 | N-Q | American Century Strategic Asset Allocations Inc - Newton Fund | Small-Cap Core | 27,400 | New Holding | 27,400 | 100 % | $906,940 | $1,055,996 | $149,056 | 16.43 % | $149,056 | | | | | | News Article | History of American Century Strategic Asset Allocations Inc - Newton Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-28 | 2009-08-31 | N-Q | Brazos Mutual Funds - Brazos Growth Portfolio | Mid-Cap Growth | | Sold All | -15,700 | -100 % | | | | 16.43 % | $-85,408 | | | | | | News Article | History of Brazos Mutual Funds - Brazos Growth Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-28 | 2009-08-31 | N-Q | Brazos Mutual Funds - Brazos Mid Cap Portfolio | Mid-Cap Growth | | Sold All | -14,300 | -100 % | | | | 16.43 % | $-77,792 | | | | | | News Article | History of Brazos Mutual Funds - Brazos Mid Cap Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-28 | 2009-08-31 | N-Q | Dws Securities Trust - Dws Health Care Fund | Health/Biotech | 30,900 | Added More | 13,800 | 80.70 % | $1,022,790 | $1,190,886 | $168,096 | 16.43 % | $75,072 | | | | | | News Article | History of Dws Securities Trust - Dws Health Care Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-28 | 2009-08-31 | N-CSR | Oppenheimer Capital Appreciation Fund - Oppenheimer Capital Appreciation Fund | Large-Cap Growth | 732,270 | New Holding | 732,270 | 100 % | $24,238,137 | $28,221,686 | $3,983,549 | 16.43 % | $3,983,549 | | | | | | News Article | History of Oppenheimer Capital Appreciation Fund - Oppenheimer Capital Appreciation Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-28 | 2009-08-31 | N-Q | Proshares Trust - Ultra Qqq Proshares | Specialty & Misc | 90,178 | Sold Some | -83,842 | -48.17 % | $2,984,892 | $3,475,460 | $490,568 | 16.43 % | $-456,100 | | | | | | News Article | History of Proshares Trust - Ultra Qqq Proshares Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Essex Investment Management Co Llc | Institution | 223,775 | Added More | 1,336 | 0.60 % | $7,467,372 | $8,624,289 | $1,156,917 | 15.49 % | $6,907 | | | | | | News Article | History of Essex Investment Management Co Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | First Manhattan Co | Institution | 6,705 | Sold Some | -4,000 | -37.36 % | $223,746 | $258,411 | $34,665 | 15.49 % | $-20,680 | | | | | | News Article | History of First Manhattan Co Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | North American Management Corp | Institution | 8,595 | Sold Some | -8,595 | -50.00 % | $286,815 | $331,251 | $44,436 | 15.49 % | $-44,436 | | | | | | News Article | History of North American Management Corp Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Wagner Investment Management Inc | Institution | 260 | No Change | 0 | 0 % | $8,676 | $10,020 | $1,344 | 15.49 % | $0 | | | | | | News Article | History of Wagner Investment Management Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-26 | 2009-09-30 | 13F-HR | Schroder Investment Management Group | Institution | 12,973 | New Holding | 12,973 | 100 % | $416,563 | $499,979 | $83,416 | 20.02 % | $83,416 | | | | | | News Article | History of Schroder Investment Management Group Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-26 | 2009-09-30 | 13F-HR | Texan Capital Management | No Data | 27,382 | Sold Some | -3,716 | -11.94 % | $879,236 | $1,055,302 | $176,066 | 20.02 % | $-23,894 | | | | | | News Article | History of Texan Capital Management Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Claymore Exchange Traded Fund Trust - Claymoremorningstar Services Super Sector Index Etf | Specialty & Misc | 90 | No Change | 0 | 0 % | $2,890 | $3,469 | $579 | 20.02 % | $0 | | | | | | News Article | History of Claymore Exchange Traded Fund Trust - Claymoremorningstar Services Super Sector Index Etf Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Legg Mason Partners Equity Trust - Legg Mason Partners Mid Cap Core Fund | Mid-Cap Core | | Sold All | -200,000 | -100 % | | | | 20.02 % | $-1,286,000 | | | | | | News Article | History of Legg Mason Partners Equity Trust - Legg Mason Partners Mid Cap Core Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-26 | 2009-06-30 | 13F-HR/A | Ameriprise Financial Inc | Institution | 458,380 | Sold Some | -5,484 | -1.18 % | $14,718,582 | $17,665,965 | $2,947,383 | 20.02 % | $-35,262 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Cambridge Investment Research Advisors Inc | Institution | 19,428 | Added More | 2,979 | 18.11 % | $631,410 | $748,755 | $117,345 | 18.58 % | $17,993 | | | | | | News Article | History of Cambridge Investment Research Advisors Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Columbus Circle Investors | Institution | | Sold All | -183,041 | -100 % | | | | 18.58 % | $-1,105,568 | | | | | | News Article | History of Columbus Circle Investors Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-23 | 2009-09-30 | 13F-HR | Pinnacle Associates Ltd | Institution | 24,300 | No Change | 0 | 0 % | $789,750 | $936,522 | $146,772 | 18.58 % | $0 | | | | | | News Article | History of Pinnacle Associates Ltd Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Advisors Llc | Institution | 1,683,910 | Added More | 173,600 | 11.49 % | $55,417,478 | $64,897,891 | $9,480,413 | 17.10 % | $977,368 | | | | | | News Article | History of Blackrock Advisors Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Group Ltd | Institution | 1,164,392 | Added More | 285,146 | 32.43 % | $38,320,141 | $44,875,668 | $6,555,527 | 17.10 % | $1,605,372 | | | | | | News Article | History of Blackrock Group Ltd Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Inc | No Data | 402,887 | Sold Some | -36,301 | -8.26 % | $13,259,011 | $15,527,265 | $2,268,254 | 17.10 % | $-204,375 | | | | | | News Article | History of Blackrock Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Investment Management Llc | Institution | 618,365 | Added More | 218,922 | 54.80 % | $20,350,392 | $23,831,787 | $3,481,395 | 17.10 % | $1,232,531 | | | | | | News Article | History of Blackrock Investment Management Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR/A | Founders Bank And Trust | Institution | 160 | No Change | 0 | 0 % | $5,266 | $6,166 | $901 | 17.10 % | $0 | | | | | | News Article | History of Founders Bank And Trust Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Merrill Lynch Mercury Asset Management Japan Ltd | Institution | 527,791 | Added More | 194,351 | 58.28 % | $17,369,602 | $20,341,065 | $2,971,463 | 17.10 % | $1,094,196 | | | | | | News Article | History of Merrill Lynch Mercury Asset Management Japan Ltd Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR/A | Ned Davis Research | Institution | | Sold All | -20,150 | -100 % | | | | 17.10 % | $-113,445 | | | | | | News Article | History of Ned Davis Research Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Oakbrook Investments Llc | Institution | 26,200 | Added More | 50 | 0.19 % | $862,242 | $1,009,748 | $147,506 | 17.10 % | $282 | | | | | | News Article | History of Oakbrook Investments Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Regions Financial Corp | Institution | 15,520 | Added More | 216 | 1.41 % | $510,763 | $598,141 | $87,378 | 17.10 % | $1,216 | | | | | | News Article | History of Regions Financial Corp Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 5,640,899 | Sold Some | -379,678 | -6.30 % | $185,585,577 | $217,400,247 | $31,814,670 | 17.14 % | $-2,141,384 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | State Board Of Administration Of Florida Retirement System | Institution | 492,122 | Added More | 63,650 | 14.85 % | $16,190,814 | $18,966,382 | $2,775,568 | 17.14 % | $358,986 | | | | | | News Article | History of State Board Of Administration Of Florida Retirement System Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Public Employees Retirement Association Of Colorado | Institution | 203,700 | Added More | 7,800 | 3.98 % | $6,768,951 | $7,850,598 | $1,081,647 | 15.97 % | $41,418 | | | | | | News Article | History of Public Employees Retirement Association Of Colorado Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Teachers Retirement System Of The State Of Kentucky | Institution | 85,629 | No Change | 0 | 0 % | $2,845,452 | $3,300,142 | $454,690 | 15.97 % | $0 | | | | | | News Article | History of Teachers Retirement System Of The State Of Kentucky Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Hanseatic Management Services Inc | Institution | 22,280 | New Holding | 22,280 | 100 % | $776,012 | $858,671 | $82,659 | 10.65 % | $82,659 | | | | | | News Article | History of Hanseatic Management Services Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Strs Ohio | Institution | 5,100 | Sold Some | -2,700 | -34.61 % | $177,633 | $196,554 | $18,921 | 10.65 % | $-10,017 | | | | | | News Article | History of Strs Ohio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-16 | 2009-09-30 | 13F-HR | Amg National Trust Bank | Institution | 6,000 | No Change | 0 | 0 % | $209,100 | $231,240 | $22,140 | 10.58 % | $0 | | | | | | News Article | History of Amg National Trust Bank Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-16 | 2009-09-30 | 13F-HR | Capstone Asset Management Co | Institution | 12,980 | Added More | 340 | 2.68 % | $452,353 | $500,249 | $47,896 | 10.58 % | $1,255 | | | | | | News Article | History of Capstone Asset Management Co Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-16 | 2009-09-30 | 13F-HR | Members Capital Advisors Inc | Institution | | Sold All | -85,300 | -100 % | | | | 10.58 % | $-314,757 | | | | | | News Article | History of Members Capital Advisors Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-16 | 2009-09-30 | 13F-HR | Welch And Forbes Llc | Institution | 231,550 | Sold Some | -16,650 | -6.70 % | $8,069,518 | $8,923,937 | $854,420 | 10.58 % | $-61,439 | | | | | | News Article | History of Welch And Forbes Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Managers Investment Group Llc | Institution | 10,323 | Sold Some | -225 | -2.13 % | $363,989 | $397,848 | $33,859 | 9.30 % | $-738 | | | | | | News Article | History of Managers Investment Group Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Nordea Investment Management Ab | Institution | 10,059 | Sold Some | -155,900 | -93.93 % | $354,680 | $387,674 | $32,994 | 9.30 % | $-511,352 | | | | | | News Article | History of Nordea Investment Management Ab Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Pillar Point Equity Management Llc | Institution | 4,600 | No Change | 0 | 0 % | $162,196 | $177,284 | $15,088 | 9.30 % | $0 | | | | | | News Article | History of Pillar Point Equity Management Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Public Employees Retirement System Of Ohio | Institution | 426,538 | Added More | 11,529 | 2.77 % | $15,039,730 | $16,438,775 | $1,399,045 | 9.30 % | $37,815 | | | | | | News Article | History of Public Employees Retirement System Of Ohio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR/A | Standard Life Investments | Institution | 9,800 | No Change | 0 | 0 % | $345,548 | $377,692 | $32,144 | 9.30 % | $0 | | | | | | News Article | History of Standard Life Investments Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR/A | Standard Life Investments | Institution | 969,183 | Added More | 959,383 | 9789.62 % | $34,173,393 | $37,352,313 | $3,178,920 | 9.30 % | $3,146,776 | | | | | | News Article | History of Standard Life Investments Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-14 | 2009-09-30 | 13F-HR | Dorsey Wright Associates | Institution | 56,396 | Sold Some | -5,013 | -8.16 % | $1,935,511 | $2,173,502 | $237,991 | 12.29 % | $-21,155 | | | | | | News Article | History of Dorsey Wright Associates Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-14 | 2009-09-30 | 13F-HR | Granahan Investment Management Inc | Institution | 514,497 | No Change | 0 | 0 % | $17,657,537 | $19,828,714 | $2,171,177 | 12.29 % | $0 | | | | | | News Article | History of Granahan Investment Management Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-14 | 2009-09-30 | 13F-HR | Shell Asset Management Co | Institution | 78,537 | Added More | 22,706 | 40.66 % | $2,695,390 | $3,026,816 | $331,426 | 12.29 % | $95,819 | | | | | | News Article | History of Shell Asset Management Co Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-09 | 2009-07-31 | N-CSR | First Trust Exchange-Traded Alphadex Fund - First Trust Health Care Alphadex Fund | Health/Biotech | | Sold All | -1,882 | -100 % | | | | 14.19 % | $-9,015 | | | | | | News Article | History of First Trust Exchange-Traded Alphadex Fund - First Trust Health Care Alphadex Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-09 | 2009-07-31 | N-CSR | Lord Abbett Large Cap Growth Fund - Lord Abbett Large Cap Growth Fund | Large-Cap Growth | 58,000 | Added More | 10,000 | 20.83 % | $1,957,500 | $2,235,320 | $277,820 | 14.19 % | $47,900 | | | | | | News Article | History of Lord Abbett Large Cap Growth Fund - Lord Abbett Large Cap Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-08 | 2009-09-30 | 13F-HR | Rhumbline Advisers | Institution | 315,175 | Sold Some | -5,553 | -1.73 % | $10,451,203 | $12,146,845 | $1,695,642 | 16.22 % | $-29,875 | | | | | | News Article | History of Rhumbline Advisers Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-08 | 2009-07-31 | N-CSR | Morgan Stanley Strategist Fund - None | Specialty & Misc | 156,300 | No Change | 0 | 0 % | $5,182,908 | $6,023,802 | $840,894 | 16.22 % | $0 | | | | | | News Article | History of Morgan Stanley Strategist Fund - None Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-08 | 2008-07-31 | N-CSR | Morgan Stanley Health Sciences Trust - None | Specialty & Misc | | Sold All | -208,900 | -100 % | | | | 16.22 % | $-1,123,882 | | | | | | News Article | History of Morgan Stanley Health Sciences Trust - None Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund | Health/Biotech | 144,408 | Added More | 87,904 | 155.57 % | $4,873,770 | $5,565,484 | $691,714 | 14.19 % | $421,060 | | | | | | News Article | History of Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Profunds - Bull Profund | Large-Cap Core | 34,005 | Added More | 1,882 | 5.85 % | $1,147,669 | $1,310,553 | $162,884 | 14.19 % | $9,015 | | | | | | News Article | History of Profunds - Bull Profund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Profunds - Health Care Ultrasector Profund | Health/Biotech | 730 | Added More | 390 | 114.70 % | $24,638 | $28,134 | $3,497 | 14.19 % | $1,868 | | | | | | News Article | History of Profunds - Health Care Ultrasector Profund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Profunds - Technology Ultrasector Profund | Science & Tech | 8,704 | New Holding | 8,704 | 100 % | $293,760 | $335,452 | $41,692 | 14.19 % | $41,692 | | | | | | News Article | History of Profunds - Technology Ultrasector Profund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-06 | 2009-09-30 | 13F-HR | Agran Libbie | Institution | 19,375 | Added More | 1,000 | 5.44 % | $653,906 | $746,713 | $92,806 | 14.19 % | $4,790 | | | | | | News Article | History of Agran Libbie Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-05 | 2009-09-30 | 13F-HR | Bb And T Corp | Institution | 5,965 | New Holding | 5,965 | 100 % | $201,498 | $229,891 | $28,393 | 14.09 % | $28,393 | | | | | | News Article | History of Bb And T Corp Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Alliancebernstein Mid Cap Growth Fund Inc - Alliancebernstein Mid Cap Growth Fund Inc | Mid-Cap Growth | 89,900 | Added More | 21,900 | 32.20 % | $3,145,601 | $3,464,746 | $319,145 | 10.14 % | $77,745 | | | | | | News Article | History of Alliancebernstein Mid Cap Growth Fund Inc - Alliancebernstein Mid Cap Growth Fund Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Alliancebernstein Portfolios - Alliancebernstein Growth Fund | Multi-Cap Growth | 66,400 | New Holding | 66,400 | 100 % | $2,323,336 | $2,559,056 | $235,720 | 10.14 % | $235,720 | | | | | | News Article | History of Alliancebernstein Portfolios - Alliancebernstein Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Old Mutual Advisor Funds - Old Mutual Copper Rock Emerging Growth Fund | Small-Cap Growth | | Sold All | -14,104 | -100 % | | | | 10.14 % | $-50,069 | | | | | | News Article | History of Old Mutual Advisor Funds - Old Mutual Copper Rock Emerging Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Pacific Capital Funds - Value Fund | Multi-Cap Core | 2,000 | New Holding | 2,000 | 100 % | $69,980 | $77,080 | $7,100 | 10.14 % | $7,100 | | | | | | News Article | History of Pacific Capital Funds - Value Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Value Fund | Multi-Cap Value | 22,600 | Added More | 6,650 | 41.69 % | $790,774 | $871,004 | $80,230 | 10.14 % | $23,608 | | | | | | News Article | History of Usaa Mutual Funds Trust - Value Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | American Century Mutual Funds Inc - Capital Growth Fund | Large-Cap Growth | 3,100 | New Holding | 3,100 | 100 % | $117,149 | $119,474 | $2,325 | 1.98 % | $2,325 | | | | | | News Article | History of American Century Mutual Funds Inc - Capital Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | American Century Mutual Funds Inc - Growth Fund | Large-Cap Growth | 441,200 | New Holding | 441,200 | 100 % | $16,672,948 | $17,003,848 | $330,900 | 1.98 % | $330,900 | | | | | | News Article | History of American Century Mutual Funds Inc - Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Core Equity Portfolio | International Small-Mid-Cap Value | 46,300 | New Holding | 46,300 | 100 % | $1,749,677 | $1,784,402 | $34,725 | 1.98 % | $34,725 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Core Equity Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio | No Data | 1,600 | New Holding | 1,600 | 100 % | $60,464 | $61,664 | $1,200 | 1.98 % | $1,200 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio | No Data | 1,000 | New Holding | 1,000 | 100 % | $37,790 | $38,540 | $750 | 1.98 % | $750 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q/A | Eaton Vance Mutual Funds Trust - Eaton Vance Equity Research Fund | Specialty & Misc | 784 | New Holding | 784 | 100 % | $29,627 | $30,215 | $588 | 1.98 % | $588 | | | | | | News Article | History of Eaton Vance Mutual Funds Trust - Eaton Vance Equity Research Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Fidelity Capital Trust - Fidelity Stock Selector | Specialty & Misc | 46,100 | Sold Some | -7,900 | -14.62 % | $1,742,119 | $1,776,694 | $34,575 | 1.98 % | $-5,925 | | | | | | News Article | History of Fidelity Capital Trust - Fidelity Stock Selector Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Fidelity Commonwealth Trust - Fidelity Large Cap Stock Fund | Large-Cap Core | 89,222 | Sold Some | -48,278 | -35.11 % | $3,371,699 | $3,438,616 | $66,917 | 1.98 % | $-36,209 | | | | | | News Article | History of Fidelity Commonwealth Trust - Fidelity Large Cap Stock Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Fidelity Investment Trust - Fidelity Canada Fund | Specialty & Misc | 200,000 | New Holding | 200,000 | 100 % | $7,558,000 | $7,708,000 | $150,000 | 1.98 % | $150,000 | | | | | | News Article | History of Fidelity Investment Trust - Fidelity Canada Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Fidelity Investment Trust - Fidelity Europe Fund | European Region | 200,000 | New Holding | 200,000 | 100 % | $7,558,000 | $7,708,000 | $150,000 | 1.98 % | $150,000 | | | | | | News Article | History of Fidelity Investment Trust - Fidelity Europe Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Hartford Mutual Funds Incct - Hartford Global Health Fund | Health/Biotech | 137 | Sold Some | -36 | -20.80 % | $5,177 | $5,280 | $103 | 1.98 % | $-27 | | | | | | News Article | History of Hartford Mutual Funds Incct - Hartford Global Health Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Ishares Trust - Ishares Morningstar Mid Growth Index Fund | Mid-Cap Growth | 39,133 | Sold Some | -10,111 | -20.53 % | $1,478,836 | $1,508,186 | $29,350 | 1.98 % | $-7,583 | | | | | | News Article | History of Ishares Trust - Ishares Morningstar Mid Growth Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Janus Investment Fund - Janus Enterprise Fund | Mid-Cap Growth | 223,025 | Added More | 90,255 | 67.97 % | $8,428,115 | $8,595,384 | $167,269 | 1.98 % | $67,691 | | | | | | News Article | History of Janus Investment Fund - Janus Enterprise Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-CSR | Janus Investment Fund - Janus Forty Fund | No Data | 1,029,390 | No Compare | | | $38,900,648 | $39,672,691 | $772,043 | 1.98 % | | | | | | | News Article | History of Janus Investment Fund - Janus Forty Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Janus Investment Fund - Janus Fund | Large-Cap Growth | 245,425 | New Holding | 245,425 | 100 % | $9,274,611 | $9,458,680 | $184,069 | 1.98 % | $184,069 | | | | | | News Article | History of Janus Investment Fund - Janus Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Janus Investment Fund - Janus Global Technology Fund | Science & Tech | 142,650 | Added More | 39,535 | 38.34 % | $5,390,744 | $5,497,731 | $106,988 | 1.98 % | $29,651 | | | | | | News Article | History of Janus Investment Fund - Janus Global Technology Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Janus Investment Fund - Janus Orion Fund | Multi-Cap Growth | 462,395 | Sold Some | -198,635 | -30.04 % | $17,473,907 | $17,820,703 | $346,796 | 1.98 % | $-148,976 | | | | | | News Article | History of Janus Investment Fund - Janus Orion Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Janus Investment Fund - Janus Worldwide Fund | Global Large-Cap Growth | 658,195 | New Holding | 658,195 | 100 % | $24,873,189 | $25,366,835 | $493,646 | 1.98 % | $493,646 | | | | | | News Article | History of Janus Investment Fund - Janus Worldwide Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Jnl Investors Series Trust - Jackson Perspective Index 5 Fund | Specialty & Misc | 1,923 | No Change | 0 | 0 % | $72,670 | $74,112 | $1,442 | 1.98 % | $0 | | | | | | News Article | History of Jnl Investors Series Trust - Jackson Perspective Index 5 Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Mainstay Funds - Mainstay Common Stock Fund | Large-Cap Core | | Sold All | -3,761 | -100 % | | | | 1.98 % | $-2,821 | | | | | | News Article | History of Mainstay Funds - Mainstay Common Stock Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-CSR | Pioneer Series Trust Iv - Pioneer Classic Balanced Fund | Flexible Portfolio | | Sold All | -12,586 | -100 % | | | | 1.98 % | $-9,440 | | | | | | News Article | History of Pioneer Series Trust Iv - Pioneer Classic Balanced Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-CSR | Putnam Vista Fundnew - Putnam Vista Fundnew | Mid-Cap Growth | | Sold All | -178,600 | -100 % | | | | 1.98 % | $-133,950 | | | | | | News Article | History of Putnam Vista Fundnew - Putnam Vista Fundnew Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Russell Investment Co - International Fund | International Multi-Cap Core | | Sold All | -5,739 | -100 % | | | | 1.98 % | $-4,304 | | | | | | News Article | History of Russell Investment Co - International Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Van Kampen Trust Ii - Global Tactical Asset Allocation Fund | No Data | 100 | No Change | 0 | 0 % | $3,779 | $3,854 | $75 | 1.98 % | $0 | | | | | | News Article | History of Van Kampen Trust Ii - Global Tactical Asset Allocation Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Vanguard Explorer Fund - Vanguard Explorer Fund | Small-Cap Growth | 474,547 | Sold Some | -184,443 | -27.98 % | $17,933,131 | $18,289,041 | $355,910 | 1.98 % | $-138,332 | | | | | | News Article | History of Vanguard Explorer Fund - Vanguard Explorer Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Harbor Funds - Harbor Capital Appreciation Fund | Large-Cap Growth | 1,069,200 | No Change | 0 | 0 % | $40,298,148 | $41,206,968 | $908,820 | 2.25 % | $0 | | | | | | News Article | History of Harbor Funds - Harbor Capital Appreciation Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Harbor Funds - Harbor Small Cap Growth Fund | Small-Cap Growth | 264,050 | Added More | 600 | 0.22 % | $9,952,045 | $10,176,487 | $224,443 | 2.25 % | $510 | | | | | | News Article | History of Harbor Funds - Harbor Small Cap Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Jpmorgan Trust I - Jpmorgan Intrepid International Fund | Global Flex Port | | Sold All | -42 | -100 % | | | | 2.25 % | $-36 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Intrepid International Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Legg Mason Partners Equity Trust - Legg Mason Partners Diversified Large Cap Growth Fund | Large-Cap Growth | | Sold All | -64,000 | -100 % | | | | 2.25 % | $-54,400 | | | | | | News Article | History of Legg Mason Partners Equity Trust - Legg Mason Partners Diversified Large Cap Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Legg Mason Partners Equity Trust - Legg Mason Partners Large Cap Growth Fund | Large-Cap Growth | | Sold All | -1,650,000 | -100 % | | | | 2.25 % | $-1,402,500 | | | | | | News Article | History of Legg Mason Partners Equity Trust - Legg Mason Partners Large Cap Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Legg Mason Partners Variable Equity Trust - Legg Mason Partners Variable Large Cap Growth Portfolio | Large-Cap Growth | 124,055 | Sold Some | -6,950 | -5.30 % | $4,675,633 | $4,781,080 | $105,447 | 2.25 % | $-5,908 | | | | | | News Article | History of Legg Mason Partners Variable Equity Trust - Legg Mason Partners Variable Large Cap Growth Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Legg Mason Partners Variable Equity Trust - Legg Mason Partners Variable Mid Cap Core Portfolio | Mid-Cap Core | 18,900 | Sold Some | -1,100 | -5.50 % | $712,341 | $728,406 | $16,065 | 2.25 % | $-935 | | | | | | News Article | History of Legg Mason Partners Variable Equity Trust - Legg Mason Partners Variable Mid Cap Core Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Capital Appreciation Fund | Specialty & Misc | 94,750 | Sold Some | -450 | -0.47 % | $3,571,128 | $3,651,665 | $80,538 | 2.25 % | $-383 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Capital Appreciation Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange Traded Fund Trust - Powershares Dividend Achievers Portfolio | Specialty & Misc | 4,130 | New Holding | 4,130 | 100 % | $155,660 | $159,170 | $3,511 | 2.25 % | $3,511 | | | | | | News Article | History of Powershares Exchange Traded Fund Trust - Powershares Dividend Achievers Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange-Traded Fund Trust Ii - Powershares Global Biotech Portfolio | No Data | 2,753 | Sold Some | -424 | -13.34 % | $103,761 | $106,101 | $2,340 | 2.25 % | $-360 | | | | | | News Article | History of Powershares Exchange-Traded Fund Trust Ii - Powershares Global Biotech Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-28 | 2009-06-30 | 13F-HR/A | Bridgewater Investment Management Llc | Institution | | Sold All | -270 | -100 % | | | | 2.25 % | $-230 | | | | | | News Article | History of Bridgewater Investment Management Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Advantage Funds Inc - Global Alpha Fund | Global Flex Port | 412 | Sold Some | -324 | -44.02 % | $14,993 | $15,878 | $886 | 5.90 % | $-697 | | | | | | News Article | History of Advantage Funds Inc - Global Alpha Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Direxion Shares Etf Trust - Direxion Daily Large Cap Bull 3x Shares | No Data | | Sold All | -12,901 | -100 % | | | | 5.90 % | $-27,737 | | | | | | News Article | History of Direxion Shares Etf Trust - Direxion Daily Large Cap Bull 3x Shares Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Direxion Shares Etf Trust - Direxion Daily Mid Cap Bull 3x Shares | No Data | 1,690 | Added More | 988 | 140.74 % | $61,499 | $65,133 | $3,634 | 5.90 % | $2,124 | | | | | | News Article | History of Direxion Shares Etf Trust - Direxion Daily Mid Cap Bull 3x Shares Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-25 | 2009-06-30 | 13F-HR/A | Kbc Group Nv | Institution | 59,441 | No Change | 0 | 0 % | $2,163,058 | $2,290,856 | $127,798 | 5.90 % | $0 | | | | | | News Article | History of Kbc Group Nv Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-24 | 2009-07-31 | N-Q | Dreyfus Midcap Index Fund Inc - Dreyfus Midcap Index Fund Inc | Mid-Cap Core | 351,668 | New Holding | 351,668 | 100 % | $12,670,598 | $13,553,285 | $882,687 | 6.96 % | $882,687 | | | | | | News Article | History of Dreyfus Midcap Index Fund Inc - Dreyfus Midcap Index Fund Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-24 | 2009-07-31 | N-Q | Forum Funds - Shaker Fund | Specialty & Misc | 5,800 | New Holding | 5,800 | 100 % | $208,974 | $223,532 | $14,558 | 6.96 % | $14,558 | | | | | | News Article | History of Forum Funds - Shaker Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-24 | 2009-07-31 | N-Q | Members Mutual Funds - Large Cap Growth Fund | No Data | | Sold All | -20,500 | -100 % | | | | 6.96 % | $-51,455 | | | | | | News Article | History of Members Mutual Funds - Large Cap Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-24 | 2009-07-31 | N-Q | Nationwide Mutual Funds - Nationwide Mid Cap Market Index Fund | Mid-Cap Core | | Sold All | -132,290 | -100 % | | | | 6.96 % | $-332,048 | | | | | | News Article | History of Nationwide Mutual Funds - Nationwide Mid Cap Market Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-24 | 2009-06-30 | 13F-HR/A | Credit Agricole S A | Institution | 31,435 | Sold Some | -3,463 | -9.92 % | $1,132,603 | $1,211,505 | $78,902 | 6.96 % | $-8,692 | | | | | | News Article | History of Credit Agricole S A Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-23 | 2009-07-31 | N-Q | Dreyfus Growth And Income Fund Inc New - Dreyfus Growth And Income Fund Inc New | Multi-Cap Growth | 41,250 | New Holding | 41,250 | 100 % | $1,505,625 | $1,589,775 | $84,150 | 5.58 % | $84,150 | | | | | | News Article | History of Dreyfus Growth And Income Fund Inc New - Dreyfus Growth And Income Fund Inc New Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-22 | 2009-07-31 | N-Q | Dreyfus Premier Opportunity Funds - Health Care Fund | Health/Biotech | 21,720 | Added More | 600 | 2.84 % | $803,206 | $837,089 | $33,883 | 4.21 % | $936 | | | | | | News Article | History of Dreyfus Premier Opportunity Funds - Health Care Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-22 | 2009-07-31 | N-Q | Dreyfuslaurel Funds Inc - Midcap Stock Fund | Mid-Cap Core | 142,080 | Added More | 19,610 | 16.01 % | $5,254,118 | $5,475,763 | $221,645 | 4.21 % | $30,592 | | | | | | News Article | History of Dreyfuslaurel Funds Inc - Midcap Stock Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-21 | 2009-06-30 | 13F-HR/A | Eaton Vance Management | Institution | 96,348 | New Holding | 96,348 | 100 % | $3,671,822 | $3,713,252 | $41,430 | 1.12 % | $41,430 | | | | | | News Article | History of Eaton Vance Management Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-21 | 2009-06-30 | 13F-HR/A | Eaton Vance Management | Institution | 96,453 | New Holding | 96,453 | 100 % | $3,675,824 | $3,717,299 | $41,475 | 1.12 % | $41,475 | | | | | | News Article | History of Eaton Vance Management Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-17 | 2009-06-30 | 13F-HR/A | Delaware Management Business Trust | Institution | 20,269 | Added More | 10,139 | 100.08 % | $769,209 | $781,167 | $11,959 | 1.55 % | $5,982 | | | | | | News Article | History of Delaware Management Business Trust Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-15 | 2009-06-30 | N-CSRS/A | Wilshire Mutual Funds Inc - Wilshire Large Cap Core 13030 Fund | No Data | | Sold All | -2,200 | -100 % | | | | 4.21 % | $-3,432 | | | | | | News Article | History of Wilshire Mutual Funds Inc - Wilshire Large Cap Core 13030 Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 8,825,640 | Added More | 659,372 | 8.07 % | $317,016,989 | $340,140,166 | $23,123,177 | 7.29 % | $1,727,555 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 8,933,683 | Added More | 767,415 | 9.39 % | $320,897,893 | $344,304,143 | $23,406,249 | 7.29 % | $2,010,627 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-10 | 2009-06-30 | 13F-HR/A | Veritable L P | Institution | 11,731 | Sold Some | -830 | -6.60 % | $422,785 | $452,113 | $29,328 | 6.93 % | $-2,075 | | | | | | News Article | History of Veritable L P Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-10 | 2009-03-31 | 13F-HR/A | Veritable L P | Institution | 12,561 | Added More | 2,470 | 24.47 % | $452,698 | $484,101 | $31,403 | 6.93 % | $6,175 | | | | | | News Article | History of Veritable L P Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Allianz Variable Insurance Products Trust - Azl Mid Cap Index Fund | No Data | 6,731 | No Compare | | | $247,095 | $259,413 | $12,318 | 4.98 % | | | | | | | News Article | History of Allianz Variable Insurance Products Trust - Azl Mid Cap Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Morgan Stanley Variable Investment Series - Information Portfolio | Specialty & Misc | 49,595 | New Holding | 49,595 | 100 % | $1,820,632 | $1,911,391 | $90,759 | 4.98 % | $90,759 | | | | | | News Article | History of Morgan Stanley Variable Investment Series - Information Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSR | Nuveen Investment Trust - Nuveen Enhanced Mid-Cap Fund | No Data | 10 | New Holding | 10 | 100 % | $367 | $385 | $18 | 4.98 % | $18 | | | | | | News Article | History of Nuveen Investment Trust - Nuveen Enhanced Mid-Cap Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSR | Revenueshares Etf Trust - Revenueshares Mid Cap Fund | Mid-Cap Core | 163 | Added More | 80 | 96.38 % | $5,984 | $6,282 | $298 | 4.98 % | $146 | | | | | | News Article | History of Revenueshares Etf Trust - Revenueshares Mid Cap Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Series Funds - Banking Fund | Financial Services | 98,055 | Added More | 33,585 | 52.09 % | $3,599,599 | $3,779,040 | $179,441 | 4.98 % | $61,461 | | | | | | News Article | History of Rydex Series Funds - Banking Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Variable Trust - Biotechnology Fund | Health/Biotech | 40,017 | Added More | 2,991 | 8.07 % | $1,469,024 | $1,542,255 | $73,231 | 4.98 % | $5,474 | | | | | | News Article | History of Rydex Variable Trust - Biotechnology Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Variable Trust - Health Care Fund | Health/Biotech | 5,984 | Sold Some | -1,796 | -23.08 % | $219,673 | $230,623 | $10,951 | 4.98 % | $-3,287 | | | | | | News Article | History of Rydex Variable Trust - Health Care Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Summit Mutual Funds Inc - Zenith Portfolio | Specialty & Misc | 24,070 | Added More | 3,035 | 14.42 % | $883,610 | $927,658 | $44,048 | 4.98 % | $5,554 | | | | | | News Article | History of Summit Mutual Funds Inc - Zenith Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Touchstone Variable Series Trust - Balanced Fund | Flexible Portfolio | 11,450 | New Holding | 11,450 | 100 % | $420,330 | $441,283 | $20,954 | 4.98 % | $20,954 | | | | | | News Article | History of Touchstone Variable Series Trust - Balanced Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-08-17 | N-CSR | John Hancock Trust - Capital Appreciation Trust | Specialty & Misc | 130,200 | Added More | 14,100 | 12.14 % | $4,728,864 | $5,017,908 | $289,044 | 6.11 % | $31,302 | | | | | | News Article | History of John Hancock Trust - Capital Appreciation Trust Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-08-17 | N-CSR | John Hancock Trust - Health Sciences Trust | Health/Biotech | | Sold All | -110,304 | -100 % | | | | 6.11 % | $-244,875 | | | | | | News Article | History of John Hancock Trust - Health Sciences Trust Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Advanced Series Trust - Ast Global Allocation Portfolio | Global Flex Port | | Sold All | -8,400 | -100 % | | | | 6.11 % | $-18,648 | | | | | | News Article | History of Advanced Series Trust - Ast Global Allocation Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | American Funds Insurance Series - Global Discovery Fund | Global Flex Port | 35,000 | No Change | 0 | 0 % | $1,271,200 | $1,348,900 | $77,700 | 6.11 % | $0 | | | | | | News Article | History of American Funds Insurance Series - Global Discovery Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | American Funds Insurance Series - Growth Fund | Multi-Cap Growth | 2,822,000 | Added More | 200,000 | 7.62 % | $102,495,040 | $108,759,880 | $6,264,840 | 6.11 % | $444,000 | | | | | | News Article | History of American Funds Insurance Series - Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio | Small-Cap Growth | 4,200 | Sold Some | -38,800 | -90.23 % | $152,544 | $161,868 | $9,324 | 6.11 % | $-86,136 | | | | | | News Article | History of Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqbond Index Portfolio | Specialty & Misc | 749,490 | Added More | 378,695 | 102.13 % | $27,221,477 | $28,885,345 | $1,663,868 | 6.11 % | $840,703 | | | | | | News Article | History of Eq Advisors Trust - Eqbond Index Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqinternational Growth Portfolio | Multi-Cap Growth | 41,895 | Added More | 3,500 | 9.11 % | $1,521,626 | $1,614,633 | $93,007 | 6.11 % | $7,770 | | | | | | News Article | History of Eq Advisors Trust - Eqinternational Growth Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqlord Abbett Large Cap Core Portfolio | Large-Cap Core | 19,812 | Added More | 1,439 | 7.83 % | $719,572 | $763,554 | $43,983 | 6.11 % | $3,195 | | | | | | News Article | History of Eq Advisors Trust - Eqlord Abbett Large Cap Core Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Hartford Series Fund Inc - Hartford Global Health Hls Fund | Health/Biotech | 86 | New Holding | 86 | 100 % | $3,124 | $3,314 | $191 | 6.11 % | $191 | | | | | | News Article | History of Hartford Series Fund Inc - Hartford Global Health Hls Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust I - Jpmorgan Intrepid International Fund | Global Flex Port | 42 | New Holding | 42 | 100 % | $1,525 | $1,619 | $93 | 6.11 % | $93 | | | | | | News Article | History of Jpmorgan Trust I - Jpmorgan Intrepid International Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSR | Jpmorgan Trust Ii - Jpmorgan Intrepid Mid Cap Fund | Mid-Cap Core | 42 | Sold Some | -2 | -4.54 % | $1,525 | $1,619 | $93 | 6.11 % | $-4 | | | | | | News Article | History of Jpmorgan Trust Ii - Jpmorgan Intrepid Mid Cap Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Massmutual Select Funds - Massmutual Select Mid Cap Growth Equity Ii Fund | Mid-Cap Growth | 222,000 | Sold Some | -15,000 | -6.32 % | $8,063,040 | $8,555,880 | $492,840 | 6.11 % | $-33,300 | | | | | | News Article | History of Massmutual Select Funds - Massmutual Select Mid Cap Growth Equity Ii Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Massmutual Select Funds - Massmutual Select Overseas Fund | International Multi-Cap Core | 5,225 | Added More | 661 | 14.48 % | $189,772 | $201,372 | $11,600 | 6.11 % | $1,467 | | | | | | News Article | History of Massmutual Select Funds - Massmutual Select Overseas Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Mma Praxis Mutual Funds - Mma Praxis Growth Index Fund | Large-Cap Growth | 559 | No Change | 0 | 0 % | $20,303 | $21,544 | $1,241 | 6.11 % | $0 | | | | | | News Article | History of Mma Praxis Mutual Funds - Mma Praxis Growth Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds - Bull Profund | Large-Cap Core | 32,123 | Added More | 30,881 | 2486.39 % | $1,166,707 | $1,238,020 | $71,313 | 6.11 % | $68,556 | | | | | | News Article | History of Profunds - Bull Profund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds - Profund Vp Biotechnology | Health/Biotech | 10,368 | New Holding | 10,368 | 100 % | $376,566 | $399,583 | $23,017 | 6.11 % | $23,017 | | | | | | News Article | History of Profunds - Profund Vp Biotechnology Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds - Profund Vp Health Care | Health/Biotech | 5,040 | New Holding | 5,040 | 100 % | $183,053 | $194,242 | $11,189 | 6.11 % | $11,189 | | | | | | News Article | History of Profunds - Profund Vp Health Care Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Sun Capital Advisers Trust - Sc Blue Chip Mid Cap Fund | Mid-Cap Core | 12,800 | Added More | 600 | 4.91 % | $464,896 | $493,312 | $28,416 | 6.11 % | $1,332 | | | | | | News Article | History of Sun Capital Advisers Trust - Sc Blue Chip Mid Cap Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Institutional Index Funds - Vanguard Institutional Index Fund | Specialty & Misc | 145,639 | Sold Some | -1,890 | -1.28 % | $5,289,608 | $5,612,927 | $323,319 | 6.11 % | $-4,196 | | | | | | News Article | History of Vanguard Institutional Index Funds - Vanguard Institutional Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Variable Insurance Funds - Balanced Portfolio | Flexible Portfolio | 58,361 | Added More | 1,840 | 3.25 % | $2,119,672 | $2,249,233 | $129,561 | 6.11 % | $4,085 | | | | | | News Article | History of Vanguard Variable Insurance Funds - Balanced Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Variable Insurance Funds - Small Company Growth Portfolio | Small-Cap Growth | 36,650 | New Holding | 36,650 | 100 % | $1,331,128 | $1,412,491 | $81,363 | 6.11 % | $81,363 | | | | | | News Article | History of Vanguard Variable Insurance Funds - Small Company Growth Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Westcore Trust - Westcore Midco Growth Fund | Mid-Cap Core | 44,600 | New Holding | 44,600 | 100 % | $1,619,872 | $1,718,884 | $99,012 | 6.11 % | $99,012 | | | | | | News Article | History of Westcore Trust - Westcore Midco Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Westcore Trust - Westcore Select Fund | Multi-Cap Core | | Sold All | -32,800 | -100 % | | | | 6.11 % | $-72,816 | | | | | | News Article | History of Westcore Trust - Westcore Select Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-10 | N-CSRS | Jpmorgan Insurance Trust - Jpmorgan Insurance Trust Intrepid Mid Cap Portfolio | Mid-Cap Core | | Sold All | -4,700 | -100 % | | | | 6.11 % | $-10,434 | | | | | | News Article | History of Jpmorgan Insurance Trust - Jpmorgan Insurance Trust Intrepid Mid Cap Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Advantus Series Fund Inc - Index 400 Mid-Cap Portfolio | No Data | | Sold All | -25,170 | -100 % | | | | 7.20 % | $-65,190 | | | | | | News Article | History of Advantus Series Fund Inc - Index 400 Mid-Cap Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Gartmore Variable Insurance Trust - Oppenheimer Nvit Large Cap Growth Fund | No Data | | Sold All | -450 | -100 % | | | | 7.20 % | $-1,166 | | | | | | News Article | History of Gartmore Variable Insurance Trust - Oppenheimer Nvit Large Cap Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Jnl Variable Fund Llc - Jnlmcm Healthcare Sector Fund | Health/Biotech | 34 | Added More | 18 | 112.50 % | $1,222 | $1,310 | $88 | 7.20 % | $47 | | | | | | News Article | History of Jnl Variable Fund Llc - Jnlmcm Healthcare Sector Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Managers Funds - Managers Amg Essex Large Cap Growth Fund | Large-Cap Growth | 5,195 | Sold Some | -6,928 | -57.14 % | $186,760 | $200,215 | $13,455 | 7.20 % | $-17,944 | | | | | | News Article | History of Managers Funds - Managers Amg Essex Large Cap Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund - Mml Global Fund | Global Flex Port | 955 | Added More | 51 | 5.64 % | $34,332 | $36,806 | $2,473 | 7.20 % | $132 | | | | | | News Article | History of Mml Series Investment Fund - Mml Global Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund - Mml Mid Cap Growth Fund | Mid-Cap Growth | 53,000 | Sold Some | -3,500 | -6.19 % | $1,905,350 | $2,042,620 | $137,270 | 7.20 % | $-9,065 | | | | | | News Article | History of Mml Series Investment Fund - Mml Mid Cap Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Northwestern Mutual Series Fund Inc - Balanced Portfolio | Flexible Portfolio | | Sold All | -45,015 | -100 % | | | | 7.20 % | $-116,589 | | | | | | News Article | History of Northwestern Mutual Series Fund Inc - Balanced Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Northwestern Mutual Series Fund Inc - Index 400 Stock Portfolio | No Data | | Sold All | -74,400 | -100 % | | | | 7.20 % | $-192,696 | | | | | | News Article | History of Northwestern Mutual Series Fund Inc - Index 400 Stock Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Ohio National Fund Inc - Aggressive Growth Portfolio | Small-Cap Growth | | Sold All | -4,410 | -100 % | | | | 7.20 % | $-11,422 | | | | | | News Article | History of Ohio National Fund Inc - Aggressive Growth Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Ohio National Fund Inc - Equity Portfolio | Specialty & Misc | | Sold All | -4,375 | -100 % | | | | 7.20 % | $-11,331 | | | | | | News Article | History of Ohio National Fund Inc - Equity Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Ohio National Fund Inc - Mid Cap Opportunity Portfolio | Mid-Cap Core | | Sold All | -13,990 | -100 % | | | | 7.20 % | $-36,234 | | | | | | News Article | History of Ohio National Fund Inc - Mid Cap Opportunity Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Focused 30 Portfolio | No Data | 26,120 | New Holding | 26,120 | 100 % | $939,014 | $1,006,665 | $67,651 | 7.20 % | $67,651 | | | | | | News Article | History of Pacific Select Fund - Focused 30 Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Pd Large-Cap Growth Index Portfolio | No Data | 454 | No Compare | | | $16,321 | $17,497 | $1,176 | 7.20 % | | | | | | | News Article | History of Pacific Select Fund - Pd Large-Cap Growth Index Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSR | Streettracks Series Trust - Spdr Dividend Etf | Specialty & Misc | | Sold All | -648,129 | -100 % | | | | 7.20 % | $-1,678,654 | | | | | | News Article | History of Streettracks Series Trust - Spdr Dividend Etf Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Met Investors Series Trust - Janus Forty Portfolio | Specialty & Misc | 291,825 | Added More | 90,700 | 45.09 % | $10,461,926 | $11,246,936 | $785,009 | 7.50 % | $243,983 | | | | | | News Article | History of Met Investors Series Trust - Janus Forty Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Met Investors Series Trust - Lazard Mid Cap Portfolio | Mid-Cap Core | 207,000 | No Change | 0 | 0 % | $7,420,950 | $7,977,780 | $556,830 | 7.50 % | $0 | | | | | | News Article | History of Met Investors Series Trust - Lazard Mid Cap Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Met Investors Series Trust - Legg Mason Partners Aggressive Growth Portfolio | Multi-Cap Growth | 166,700 | No Change | 0 | 0 % | $5,976,195 | $6,424,618 | $448,423 | 7.50 % | $0 | | | | | | News Article | History of Met Investors Series Trust - Legg Mason Partners Aggressive Growth Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Met Investors Series Trust - Oppenheimer Capital Appreciation Portfolio | Specialty & Misc | 96,290 | Added More | 15,100 | 18.59 % | $3,451,997 | $3,711,017 | $259,020 | 7.50 % | $40,619 | | | | | | News Article | History of Met Investors Series Trust - Oppenheimer Capital Appreciation Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Prudentials Gibraltar Fund - Prudentials Gibraltar Fund | Specialty & Misc | | Sold All | -19,900 | -100 % | | | | 7.50 % | $-53,531 | | | | | | News Article | History of Prudentials Gibraltar Fund - Prudentials Gibraltar Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Seligman Capital Fund Inc - Seligman Capital Fund Inc | Mid-Cap Growth | | Sold All | -66,000 | -100 % | | | | 7.50 % | $-177,540 | | | | | | News Article | History of Seligman Capital Fund Inc - Seligman Capital Fund Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Seligman Growth Fund Inc - Seligman Growth Fund Inc | Multi-Cap Growth | | Sold All | -38,500 | -100 % | | | | 7.50 % | $-103,565 | | | | | | News Article | History of Seligman Growth Fund Inc - Seligman Growth Fund Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-02 | 2009-06-30 | N-CSRS | Seligman Portfolios Incny - Seligman Capital Portfolio | Specialty & Misc | | Sold All | -1,900 | -100 % | | | | 7.50 % | $-5,111 | | | | | | News Article | History of Seligman Portfolios Incny - Seligman Capital Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Amvescap Plc | Institution | 2,009,751 | Sold Some | -2,166,271 | -51.87 % | $74,099,519 | $77,455,804 | $3,356,284 | 4.52 % | $-3,617,673 | | | | | | News Article | History of Amvescap Plc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Fmr Corp | Institution | 21,201,800 | Sold Some | -1,370,247 | -6.07 % | $781,710,366 | $817,117,372 | $35,407,006 | 4.52 % | $-2,288,312 | | | | | | News Article | History of Fmr Corp Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | N-CSRS | Neuberger Berman Advisers Management Trust - Balanced Portfolio | Flexible Portfolio | 2,900 | Added More | 1,000 | 52.63 % | $106,923 | $111,766 | $4,843 | 4.52 % | $1,670 | | | | | | News Article | History of Neuberger Berman Advisers Management Trust - Balanced Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | N-CSRS | Neuberger Berman Advisers Management Trust - Growth Portfolio | Multi-Cap Growth | 22,700 | New Holding | 22,700 | 100 % | $836,949 | $874,858 | $37,909 | 4.52 % | $37,909 | | | | | | News Article | History of Neuberger Berman Advisers Management Trust - Growth Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | N-Q/A | Rydex Series Funds - Biotechnology Fund | Health/Biotech | 117,913 | Added More | 29,830 | 33.86 % | $4,347,452 | $4,544,367 | $196,915 | 4.52 % | $49,816 | | | | | | News Article | History of Rydex Series Funds - Biotechnology Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | N-Q/A | Rydex Series Funds - Health Care Fund | Health/Biotech | 7,445 | Added More | 354 | 4.99 % | $274,497 | $286,930 | $12,433 | 4.52 % | $591 | | | | | | News Article | History of Rydex Series Funds - Health Care Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q/A | Assetmark Funds - Assetmark Large Cap Growth Fund | Large-Cap Growth | 14,734 | New Holding | 14,734 | 100 % | $551,199 | $567,848 | $16,649 | 3.02 % | $16,649 | | | | | | News Article | History of Assetmark Funds - Assetmark Large Cap Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Columbia Funds Variable Insurance Trust I - Columbia Marsico Growth Fund Variable Series | Multi-Cap Growth | 5,940 | New Holding | 5,940 | 100 % | $222,215 | $228,928 | $6,712 | 3.02 % | $6,712 | | | | | | News Article | History of Columbia Funds Variable Insurance Trust I - Columbia Marsico Growth Fund Variable Series Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Diversified Investors Funds Group - Value Fund | Multi-Cap Value | 16,300 | New Holding | 16,300 | 100 % | $609,783 | $628,202 | $18,419 | 3.02 % | $18,419 | | | | | | News Article | History of Diversified Investors Funds Group - Value Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Diversified Investors Funds Group Ii - Value Fund | Small-Cap Core | 16,300 | New Holding | 16,300 | 100 % | $609,783 | $628,202 | $18,419 | 3.02 % | $18,419 | | | | | | News Article | History of Diversified Investors Funds Group Ii - Value Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Diversified Investors Portfolios - Value Portfolio | Multi-Cap Value | 16,300 | New Holding | 16,300 | 100 % | $609,783 | $628,202 | $18,419 | 3.02 % | $18,419 | | | | | | News Article | History of Diversified Investors Portfolios - Value Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Mutual Of America Investment Corp - Bond Fund | Specialty & Misc | 2,353 | No Change | 0 | 0 % | $88,026 | $90,685 | $2,659 | 3.02 % | $0 | | | | | | News Article | History of Mutual Of America Investment Corp - Bond Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Sei Institutional Managed Trust - Global Managed Volatility Fund | Global Flex Port | | Sold All | -9,300 | -100 % | | | | 3.02 % | $-10,509 | | | | | | News Article | History of Sei Institutional Managed Trust - Global Managed Volatility Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Sei Institutional Managed Trust - Large Cap Diversified Alpha Fund | Large-Cap Core | 6,000 | Added More | 4,300 | 252.94 % | $224,460 | $231,240 | $6,780 | 3.02 % | $4,859 | | | | | | News Article | History of Sei Institutional Managed Trust - Large Cap Diversified Alpha Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Sei Institutional Managed Trust - Large Cap Growth Fund | Large-Cap Growth | | Sold All | -13,900 | -100 % | | | | 3.02 % | $-15,707 | | | | | | News Article | History of Sei Institutional Managed Trust - Large Cap Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund - Stock Index Fund | Specialty & Misc | 2,090 | Added More | 79 | 3.92 % | $78,187 | $80,549 | $2,362 | 3.02 % | $89 | | | | | | News Article | History of Tiaa Cref Life Fund - Stock Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Usaa Mutual Funds Trust - Value Fund | Multi-Cap Value | 15,950 | Sold Some | -10,850 | -40.48 % | $596,690 | $614,713 | $18,024 | 3.02 % | $-12,261 | | | | | | News Article | History of Usaa Mutual Funds Trust - Value Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSR | Allianz Funds - Occ Value | Large-Cap Value | 94,090 | Added More | 1,085 | 1.16 % | $3,513,321 | $3,626,229 | $112,908 | 3.21 % | $1,302 | | | | | | News Article | History of Allianz Funds - Occ Value Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSR | Allianz Funds - Rcm Strategic Growth Fund | Multi-Cap Growth | | Sold All | -485 | -100 % | | | | 3.21 % | $-582 | | | | | | News Article | History of Allianz Funds - Rcm Strategic Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Calvert Social Index Series Inc - Calvert Social Index Fund | Multi-Cap Core | 2,849 | Added More | 239 | 9.15 % | $106,382 | $109,800 | $3,419 | 3.21 % | $287 | | | | | | News Article | History of Calvert Social Index Series Inc - Calvert Social Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Columbia Funds Variable Insurance Trust - Columbia Asset Allocation Fund Variable Series | Specialty & Misc | 4,590 | New Holding | 4,590 | 100 % | $171,391 | $176,899 | $5,508 | 3.21 % | $5,508 | | | | | | News Article | History of Columbia Funds Variable Insurance Trust - Columbia Asset Allocation Fund Variable Series Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Columbia Funds Variable Insurance Trust - Columbia Large Cap Growth Fund Variable Series | Large-Cap Growth | 9,400 | New Holding | 9,400 | 100 % | $350,996 | $362,276 | $11,280 | 3.21 % | $11,280 | | | | | | News Article | History of Columbia Funds Variable Insurance Trust - Columbia Large Cap Growth Fund Variable Series Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Evergreen Equity Trust De - Evergreen Growth Fund | Multi-Cap Growth | | Sold All | -17,559 | -100 % | | | | 3.21 % | $-21,071 | | | | | | News Article | History of Evergreen Equity Trust De - Evergreen Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSR | First American Investment Funds Inc - International Fund | International Multi-Cap Core | | Sold All | -6 | -100 % | | | | 3.21 % | $-7 | | | | | | News Article | History of First American Investment Funds Inc - International Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Forum Funds - Absolute Strategies Fund | Equity Mkt Neutral Funds | 20,700 | New Holding | 20,700 | 100 % | $772,938 | $797,778 | $24,840 | 3.21 % | $24,840 | | | | | | News Article | History of Forum Funds - Absolute Strategies Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Nasdaq Biotechnology Index Fund | Health/Biotech | 1,446,196 | Sold Some | -25,688 | -1.74 % | $54,000,959 | $55,736,394 | $1,735,435 | 3.21 % | $-30,826 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 1000 Growth Index Fund | Multi-Cap Growth | 353,733 | Added More | 27,105 | 8.29 % | $13,208,390 | $13,632,870 | $424,480 | 3.21 % | $32,526 | | | | | | News Article | History of Ishares Trust - Ishares Russell 1000 Growth Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 1000 Index Fund | Specialty & Misc | 85,929 | Added More | 5,621 | 6.99 % | $3,208,589 | $3,311,704 | $103,115 | 3.21 % | $6,745 | | | | | | News Article | History of Ishares Trust - Ishares Russell 1000 Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Growth Index Fund | Multi-Cap Growth | 10,872 | Added More | 4 | 0.03 % | $405,960 | $419,007 | $13,046 | 3.21 % | $5 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Growth Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Index Fund | Specialty & Misc | 48,717 | Added More | 6,062 | 14.21 % | $1,819,093 | $1,877,553 | $58,460 | 3.21 % | $7,274 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Midcap Growth Index Fund | Mid-Cap Growth | 297,234 | Added More | 56,525 | 23.48 % | $11,098,718 | $11,455,398 | $356,681 | 3.21 % | $67,830 | | | | | | News Article | History of Ishares Trust - Ishares Russell Midcap Growth Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Midcap Index Fund | Mid-Cap Core | 260,419 | Sold Some | -2,199 | -0.83 % | $9,724,045 | $10,036,548 | $312,503 | 3.21 % | $-2,639 | | | | | | News Article | History of Ishares Trust - Ishares Russell Midcap Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Loomis Sayles Funds I - Loomis Sayles Bond Fund | Specialty & Misc | 1,409,794 | New Holding | 1,409,794 | 100 % | $52,641,708 | $54,333,461 | $1,691,753 | 3.21 % | $1,691,753 | | | | | | News Article | History of Loomis Sayles Funds I - Loomis Sayles Bond Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Loomis Sayles Funds I - Loomis Sayles Institutional High Income Fund | Equity Income | 165,617 | Added More | 83,030 | 100.53 % | $6,184,139 | $6,382,879 | $198,740 | 3.21 % | $99,636 | | | | | | News Article | History of Loomis Sayles Funds I - Loomis Sayles Institutional High Income Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Loomis Sayles Funds Ii - Loomis Sayles Aggressive Growth Fund | Mid-Cap Growth | | Sold All | -26,365 | -100 % | | | | 3.21 % | $-31,638 | | | | | | News Article | History of Loomis Sayles Funds Ii - Loomis Sayles Aggressive Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Loomis Sayles Funds Ii - Loomis Sayles Global Markets Fund | Global Flex Port | 26,818 | New Holding | 26,818 | 100 % | $1,001,384 | $1,033,566 | $32,182 | 3.21 % | $32,182 | | | | | | News Article | History of Loomis Sayles Funds Ii - Loomis Sayles Global Markets Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Loomis Sayles Funds Ii - Loomis Sayles Strategic Income Fund | Equity Income | 867,059 | New Holding | 867,059 | 100 % | $32,375,983 | $33,416,454 | $1,040,471 | 3.21 % | $1,040,471 | | | | | | News Article | History of Loomis Sayles Funds Ii - Loomis Sayles Strategic Income Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Northern Funds - Northern Multi-Manager Large Cap Fund | No Data | 15,000 | New Holding | 15,000 | 100 % | $560,100 | $578,100 | $18,000 | 3.21 % | $18,000 | | | | | | News Article | History of Northern Funds - Northern Multi-Manager Large Cap Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSR | Pioneer Independence Fund - Pioneer Independence Fund | Large-Cap Growth | | Sold All | -160,600 | -100 % | | | | 3.21 % | $-192,720 | | | | | | News Article | History of Pioneer Independence Fund - Pioneer Independence Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Pioneer Mid Cap Growth Fund - Pioneer Mid Cap Growth Fund | Mid-Cap Growth | 78,600 | New Holding | 78,600 | 100 % | $2,934,924 | $3,029,244 | $94,320 | 3.21 % | $94,320 | | | | | | News Article | History of Pioneer Mid Cap Growth Fund - Pioneer Mid Cap Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSR | Pioneer Research Fund - Pioneer Research Fund | Large-Cap Core | | Sold All | -19,900 | -100 % | | | | 3.21 % | $-23,880 | | | | | | News Article | History of Pioneer Research Fund - Pioneer Research Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSR | Putnam New Opportunities Fund - Putnam New Opportunities Fund | Multi-Cap Growth | | Sold All | -253,100 | -100 % | | | | 3.21 % | $-303,720 | | | | | | News Article | History of Putnam New Opportunities Fund - Putnam New Opportunities Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Putnam Variable Trust - Putnam Vt New Opportunities Fund | Specialty & Misc | | Sold All | -56,000 | -100 % | | | | 3.21 % | $-67,200 | | | | | | News Article | History of Putnam Variable Trust - Putnam Vt New Opportunities Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Putnam Variable Trust - Putnam Vt Vista Fund | Specialty & Misc | | Sold All | -45,800 | -100 % | | | | 3.21 % | $-54,960 | | | | | | News Article | History of Putnam Variable Trust - Putnam Vt Vista Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Riversource Investment Series Inc - Riversource Disciplined Large Cap Growth Fund | Large-Cap Growth | 36,656 | New Holding | 36,656 | 100 % | $1,368,735 | $1,412,722 | $43,987 | 3.21 % | $43,987 | | | | | | News Article | History of Riversource Investment Series Inc - Riversource Disciplined Large Cap Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Riversource Strategic Allocation Series Inc - Riversource Strategic Allocation Fund | Flexible Portfolio | 5,933 | New Holding | 5,933 | 100 % | $221,538 | $228,658 | $7,120 | 3.21 % | $7,120 | | | | | | News Article | History of Riversource Strategic Allocation Series Inc - Riversource Strategic Allocation Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Seasons Series Trust - Mid Cap Growth Portfolio | Mid-Cap Growth | 7,083 | New Holding | 7,083 | 100 % | $264,479 | $272,979 | $8,500 | 3.21 % | $8,500 | | | | | | News Article | History of Seasons Series Trust - Mid Cap Growth Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Seasons Series Trust - Stock Portfolio | Multi-Cap Core | 8,690 | New Holding | 8,690 | 100 % | $324,485 | $334,913 | $10,428 | 3.21 % | $10,428 | | | | | | News Article | History of Seasons Series Trust - Stock Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Variable Insurance Products Iii - Balanced Portfolio | Flexible Portfolio | 93,600 | Sold Some | -4,500 | -4.58 % | $3,495,024 | $3,607,344 | $112,320 | 3.21 % | $-5,400 | | | | | | News Article | History of Variable Insurance Products Iii - Balanced Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | 13F-HR/A | Wells Fargo And Co | Institution | 643,752 | Sold Some | -49,777 | -7.17 % | $24,037,700 | $24,810,202 | $772,502 | 3.21 % | $-59,732 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-28 | 2008-06-30 | N-Q | Vanguard Fenway Funds - Vanguard Growth Equity Fund | Large-Cap Growth | 40,600 | New Holding | 40,600 | 100 % | $1,516,004 | $1,564,724 | $48,720 | 3.21 % | $48,720 | | | | | | News Article | History of Vanguard Fenway Funds - Vanguard Growth Equity Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Janus Aspen Series - Balanced Portfolio | Mixed-Asset Target Allocation Growth | 263,045 | New Holding | 263,045 | 100 % | $9,829,992 | $10,137,754 | $307,763 | 3.13 % | $307,763 | | | | | | News Article | History of Janus Aspen Series - Balanced Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Janus Aspen Series - Forty Portfolio | Specialty & Misc | 210,075 | No Change | 0 | 0 % | $7,850,503 | $8,096,291 | $245,788 | 3.13 % | $0 | | | | | | News Article | History of Janus Aspen Series - Forty Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Janus Aspen Series - Global Life Sciences Portfolio | Science & Tech | 5,389 | New Holding | 5,389 | 100 % | $201,387 | $207,692 | $6,305 | 3.13 % | $6,305 | | | | | | News Article | History of Janus Aspen Series - Global Life Sciences Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Janus Aspen Series - Global Technology Portfolio | Science & Tech | 21,585 | Added More | 9,000 | 71.51 % | $806,631 | $831,886 | $25,254 | 3.13 % | $10,530 | | | | | | News Article | History of Janus Aspen Series - Global Technology Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Old Mutual Advisor Funds Ii - Old Mutual Growth Fund | Mid-Cap Growth | | Sold All | -29,900 | -100 % | | | | 3.13 % | $-34,983 | | | | | | News Article | History of Old Mutual Advisor Funds Ii - Old Mutual Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Oppenheimer Equity Fund Inc - Oppenheimer Equity Fund Inc | Large-Cap Core | 118,350 | New Holding | 118,350 | 100 % | $4,422,740 | $4,561,209 | $138,470 | 3.13 % | $138,470 | | | | | | News Article | History of Oppenheimer Equity Fund Inc - Oppenheimer Equity Fund Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Enhanced Large-Cap Growth Index Fund | No Data | 300 | New Holding | 300 | 100 % | $11,211 | $11,562 | $351 | 3.13 % | $351 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Enhanced Large-Cap Growth Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Equity Index Fund | Specialty & Misc | | Sold All | -8,092 | -100 % | | | | 3.13 % | $-9,468 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Equity Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Growth Equity Fund | Multi-Cap Growth | 85,165 | Added More | 2,365 | 2.85 % | $3,182,616 | $3,282,259 | $99,643 | 3.13 % | $2,767 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Growth Equity Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Van Kampen Life Investment Trust - Van Kampen Life Investment Trust Global Tactical Asset | No Data | 100 | No Compare | | | $3,737 | $3,854 | $117 | 3.13 % | | | | | | | News Article | History of Van Kampen Life Investment Trust - Van Kampen Life Investment Trust Global Tactical Asset Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard 500 Index Fund | S&P 500 Index | | Sold All | -1,762,443 | -100 % | | | | 3.13 % | $-2,062,058 | | | | | | News Article | History of Vanguard Index Funds - Vanguard 500 Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Extended Market Index Fund | Mid-Cap Core | 1,052,689 | New Holding | 1,052,689 | 100 % | $39,338,988 | $40,570,634 | $1,231,646 | 3.13 % | $1,231,646 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Extended Market Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Growth Index Fund | Large-Cap Growth | 438,513 | New Holding | 438,513 | 100 % | $16,387,231 | $16,900,291 | $513,060 | 3.13 % | $513,060 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Growth Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Total Stock Market Index Fund | Multi-Cap Core | 1,492,453 | New Holding | 1,492,453 | 100 % | $55,772,969 | $57,519,139 | $1,746,170 | 3.13 % | $1,746,170 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Total Stock Market Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Value Index Fund | Large-Cap Value | 181,840 | Added More | 60,461 | 49.81 % | $6,795,361 | $7,008,114 | $212,753 | 3.13 % | $70,739 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Value Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 52,730 | Added More | 1,250 | 2.42 % | $1,970,520 | $2,032,214 | $61,694 | 3.13 % | $1,463 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 75,730 | Added More | 24,250 | 47.10 % | $2,830,030 | $2,918,634 | $88,604 | 3.13 % | $28,373 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-26 | 2009-06-30 | 13F-HR/A | Duquesne Capital Management L L C | Institution | | Sold All | -175,000 | -100 % | | | | 4.84 % | $-311,500 | | | | | | News Article | History of Duquesne Capital Management L L C Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-26 | 2009-06-30 | N-Q | Touchstone Strategic Trust - Growth Opportunities Fund | Multi-Cap Growth | 18,100 | Added More | 2,100 | 13.12 % | $665,356 | $697,574 | $32,218 | 4.84 % | $3,738 | | | | | | News Article | History of Touchstone Strategic Trust - Growth Opportunities Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-26 | 2009-06-30 | N-Q | Vanguard Morgan Growth Fund - Vanguard Morgan Growth Fund | Multi-Cap Growth | | Sold All | -147,900 | -100 % | | | | 4.84 % | $-263,262 | | | | | | News Article | History of Vanguard Morgan Growth Fund - Vanguard Morgan Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | N-CSR | Dreyfus Fund Inc - Dreyfus Fund Inc | Large-Cap Core | | Sold All | -341,050 | -100 % | | | | 4.89 % | $-613,890 | | | | | | News Article | History of Dreyfus Fund Inc - Dreyfus Fund Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | 13F-HR | Imc-Chicago Llc | No Data | 1,019 | New Holding | 1,019 | 100 % | $37,438 | $39,272 | $1,834 | 4.89 % | $1,834 | | | | | | News Article | History of Imc-Chicago Llc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | 13F-HR/A | Jefferies Group Inc | Institution | | Sold All | -7,954 | -100 % | | | | 4.89 % | $-14,317 | | | | | | News Article | History of Jefferies Group Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | 13F-HR | Johnson Investment Counsel Inc | Institution | 14,890 | Added More | 3,245 | 27.86 % | $547,059 | $573,861 | $26,802 | 4.89 % | $5,841 | | | | | | News Article | History of Johnson Investment Counsel Inc Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | N-CSRS | Lord Abbett Series Fund Inc - International Portfolio | International Multi-Cap Core | | Sold All | -2,969 | -100 % | | | | 4.89 % | $-5,344 | | | | | | News Article | History of Lord Abbett Series Fund Inc - International Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | N-CSRS | Maxim Series Fund Inc - Maxim Janus Large Cap Growth Portfolio | No Data | 63,350 | New Holding | 63,350 | 100 % | $2,327,479 | $2,441,509 | $114,030 | 4.89 % | $114,030 | | | | | | News Article | History of Maxim Series Fund Inc - Maxim Janus Large Cap Growth Portfolio Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | N-Q | Nicholas Applegate Institutional Funds - International Growth Fund | Multi-Cap Growth | 900 | No Change | 0 | 0 % | $33,066 | $34,686 | $1,620 | 4.89 % | $0 | | | | | | News Article | History of Nicholas Applegate Institutional Funds - International Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | N-CSRS | Genworth Variable Insurance Trust - Genworth Legg Mason Partners Aggressive Growth Fund | No Data | 26,350 | No Compare | | | $969,944 | $1,015,529 | $45,586 | 4.69 % | | | | | | | News Article | History of Genworth Variable Insurance Trust - Genworth Legg Mason Partners Aggressive Growth Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | N-Q | Mellon Institutional Funds Investment Trust - The Boston Company Large Cap Core Fund | Large-Cap Core | 13,090 | New Holding | 13,090 | 100 % | $481,843 | $504,489 | $22,646 | 4.69 % | $22,646 | | | | | | News Article | History of Mellon Institutional Funds Investment Trust - The Boston Company Large Cap Core Fund Ownership Of Vertex Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | N-CSRS | Oppenheimer Variable Account Funds - Oppenheimer Capital Appreciation Fund | Specialty & Misc | 190,150 | New Holding | 190,150 | 100 % | $6,999,422 | $7,328,381 | $328,960 | 4.69 % | $328,960 | | | | | | News Article | History of Oppenheimer Variable Account Funds - Oppenheimer Capital Appreciation Fund Ownership Of Vertex Pharmaceuticals Inc |
RSS feed for VRTX